| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | peptide lactyltransferase (CoA-dependent) activity | 4.40e-05 | 2 | 133 | 2 | GO:0120300 | |
| GeneOntologyMolecularFunction | histone H3K27 acetyltransferase activity | 4.40e-05 | 2 | 133 | 2 | GO:0044017 | |
| GeneOntologyMolecularFunction | histone H3K18 acetyltransferase activity | 1.32e-04 | 3 | 133 | 2 | GO:0043993 | |
| GeneOntologyMolecularFunction | histone H2AXS139 kinase activity | 1.32e-04 | 3 | 133 | 2 | GO:0035979 | |
| GeneOntologyMolecularFunction | microtubule binding | 2.25e-04 | 308 | 133 | 9 | GO:0008017 | |
| GeneOntologyMolecularFunction | protein domain specific binding | SHANK1 DOCK1 HSP90AB4P INPP5D KIF21A CHD8 LBR CREBBP YWHAH KIF20B AFAP1L1 SCAF1 AFAP1L2 SQSTM1 PRKDC LRRFIP2 | 2.38e-04 | 875 | 133 | 16 | GO:0019904 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | TPM3 MAP2 CENPF CETN3 KIF21A CEP290 KIF16B GBP2 MYO1B NUF2 NEB YWHAH KIF20B ADD2 NDC80 XIRP2 TAOK1 EP300 | 3.66e-04 | 1099 | 133 | 18 | GO:0008092 |
| GeneOntologyMolecularFunction | histone H2AX kinase activity | 4.35e-04 | 5 | 133 | 2 | GO:0141003 | |
| GeneOntologyMolecularFunction | tubulin binding | MAP2 CENPF CETN3 KIF21A CEP290 KIF16B NUF2 KIF20B NDC80 TAOK1 | 5.97e-04 | 428 | 133 | 10 | GO:0015631 |
| GeneOntologyMolecularFunction | phosphatidylinositol bisphosphate phosphatase activity | 7.52e-04 | 27 | 133 | 3 | GO:0034593 | |
| GeneOntologyMolecularFunction | histone modifying activity | 8.72e-04 | 229 | 133 | 7 | GO:0140993 | |
| GeneOntologyMolecularFunction | ankyrin repeat binding | 9.05e-04 | 7 | 133 | 2 | GO:0071532 | |
| GeneOntologyMolecularFunction | phosphatidylinositol phosphate phosphatase activity | 1.03e-03 | 30 | 133 | 3 | GO:0052866 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.17e-03 | 118 | 133 | 5 | GO:0003774 | |
| GeneOntologyMolecularFunction | inositol bisphosphate phosphatase activity | 1.20e-03 | 8 | 133 | 2 | GO:0016312 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.23e-03 | 70 | 133 | 4 | GO:0003777 | |
| GeneOntologyMolecularFunction | structural constituent of postsynapse | 1.24e-03 | 32 | 133 | 3 | GO:0099186 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle checkpoint signaling | 9.72e-06 | 163 | 131 | 8 | GO:0007093 | |
| GeneOntologyBiologicalProcess | regulation of mitotic cell cycle | ATR CENPF CDK11A NUF2 CREBBP YWHAH CREB3L1 KIF20B AFAP1L2 NDC80 TAOK1 PRKDC MNAT1 NEK11 | 2.57e-05 | 594 | 131 | 14 | GO:0007346 |
| GeneOntologyBiologicalProcess | neutrophil differentiation | 6.84e-05 | 13 | 131 | 3 | GO:0030223 | |
| GeneOntologyBiologicalProcess | cell cycle checkpoint signaling | 7.53e-05 | 217 | 131 | 8 | GO:0000075 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle process | RAD18 ATR CENPF CDK11A NUF2 CREBBP PRPF40A YWHAH CREB3L1 KIF20B NDC80 TAOK1 PRKDC MNAT1 TXLNG NEK11 | 9.25e-05 | 845 | 131 | 16 | GO:0010564 |
| GeneOntologyBiologicalProcess | regulation of organelle organization | SHANK1 ATR MAP2 CENPF CPLX1 CDK11A NUF2 NEB YWHAH KIF20B ADD2 ASAP1 ODF2L NDC80 XIRP2 SQSTM1 TAOK1 LNPK PIP4K2C TACSTD2 EP300 | 1.09e-04 | 1342 | 131 | 21 | GO:0033043 |
| GeneOntologyBiologicalProcess | regulation of cellular response to heat | 1.32e-04 | 16 | 131 | 3 | GO:1900034 | |
| GeneOntologyCellularComponent | actin cytoskeleton | TPM3 MAP2 POTEF INPP5D ITSN1 GBP2 MYO1B NEB BIN3 ADD2 ASAP1 AFAP1L1 POTEE XIRP2 AMOT | 2.27e-06 | 576 | 127 | 15 | GO:0015629 |
| GeneOntologyCellularComponent | outer kinetochore | 1.26e-05 | 24 | 127 | 4 | GO:0000940 | |
| GeneOntologyCellularComponent | Ndc80 complex | 2.18e-04 | 4 | 127 | 2 | GO:0031262 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | PMS1 ATR CETN3 ESRRB HMGXB4 CHD8 UPF3B LBR CREBBP PRPF40A JMJD1C THOC5 BAP1 MFAP1 BAZ1A AMOT SUPT16H PRKDC CPSF2 MNAT1 | 2.38e-04 | 1377 | 127 | 20 | GO:0140513 |
| GeneOntologyCellularComponent | actin filament | 2.71e-04 | 146 | 127 | 6 | GO:0005884 | |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 2.72e-04 | 94 | 127 | 5 | GO:0000123 | |
| GeneOntologyCellularComponent | protein acetyltransferase complex | 4.35e-04 | 104 | 127 | 5 | GO:0031248 | |
| GeneOntologyCellularComponent | acetyltransferase complex | 5.39e-04 | 109 | 127 | 5 | GO:1902493 | |
| GeneOntologyCellularComponent | supramolecular fiber | TPM3 MAP2 POTEF INPP5D KIF21A LRRC49 KIF16B MYO1B NEB KIF20B PPL DNAH1 POTEE MFAP1 XIRP2 AMOT SQSTM1 | 7.89e-04 | 1179 | 127 | 17 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | TPM3 MAP2 POTEF INPP5D KIF21A LRRC49 KIF16B MYO1B NEB KIF20B PPL DNAH1 POTEE MFAP1 XIRP2 AMOT SQSTM1 | 8.50e-04 | 1187 | 127 | 17 | GO:0099081 |
| HumanPheno | Accessory spleen | 2.24e-07 | 37 | 38 | 6 | HP:0001747 | |
| HumanPheno | Abnormal location of ears | TPM3 ATR CENPF KIF21A CEP290 CPLX1 CHD8 UPF3B LBR NEB NXN CREBBP JMJD1C LETM1 BAP1 VAC14 SUPT16H TAOK1 PRKDC EP300 CUX1 | 4.07e-07 | 945 | 38 | 21 | HP:0000357 |
| HumanPheno | Supernumerary spleens | 5.41e-07 | 101 | 38 | 8 | HP:0009799 | |
| HumanPheno | Otitis media | SPAG1 CEP290 CPLX1 ARHGEF38 LBR NXN CREBBP JMJD1C LETM1 BAP1 DNAH1 TAOK1 EP300 | 1.04e-06 | 363 | 38 | 13 | HP:0000388 |
| HumanPheno | Abnormal middle ear morphology | SPAG1 CEP290 CPLX1 ARHGEF38 LBR NXN CREBBP JMJD1C LETM1 BAP1 DNAH1 TAOK1 EP300 | 2.35e-06 | 390 | 38 | 13 | HP:0008609 |
| HumanPheno | Aplasia/Hypoplasia involving bones of the skull | TPM3 ATR CENPF KIF21A CEP290 CPLX1 ARHGEF38 CHD8 UPF3B LBR NEB NXN CREBBP JMJD1C CREB3L1 LETM1 VAC14 SUPT16H EP300 | 6.38e-06 | 915 | 38 | 19 | HP:0009116 |
| HumanPheno | Micrognathia | TPM3 ATR CENPF KIF21A CEP290 CPLX1 CHD8 UPF3B LBR NEB NXN CREBBP JMJD1C CREB3L1 LETM1 VAC14 SUPT16H EP300 | 8.93e-06 | 843 | 38 | 18 | HP:0000347 |
| HumanPheno | Aplasia/Hypoplasia of the mandible | TPM3 ATR CENPF KIF21A CEP290 CPLX1 CHD8 UPF3B LBR NEB NXN CREBBP JMJD1C CREB3L1 LETM1 VAC14 SUPT16H EP300 | 9.24e-06 | 845 | 38 | 18 | HP:0009118 |
| HumanPheno | Low-set ears | TPM3 ATR CENPF UPF3B LBR NEB NXN CREBBP JMJD1C LETM1 BAP1 VAC14 SUPT16H TAOK1 PRKDC EP300 CUX1 | 1.01e-05 | 761 | 38 | 17 | HP:0000369 |
| HumanPheno | Intestinal malrotation | 1.52e-05 | 157 | 38 | 8 | HP:0002566 | |
| HumanPheno | Abnormality of the jaws | TPM3 ABAT ATR CENPF KIF21A CEP290 CPLX1 ARHGEF38 CHD8 UPF3B LBR NEB NXN CREBBP JMJD1C CREB3L1 LETM1 VAC14 SUPT16H SCN9A EP300 | 1.67e-05 | 1175 | 38 | 21 | HP:0000209 |
| HumanPheno | Abnormal jaw morphology | TPM3 ABAT ATR CENPF KIF21A CEP290 CPLX1 ARHGEF38 CHD8 UPF3B LBR NEB NXN CREBBP JMJD1C CREB3L1 LETM1 VAC14 SUPT16H SCN9A EP300 | 1.69e-05 | 1176 | 38 | 21 | HP:0030791 |
| HumanPheno | Abnormal upper lip morphology | TPM3 CEP290 CPLX1 ARHGEF38 CHD8 UPF3B LBR NEB NXN CREBBP JMJD1C LETM1 BAP1 VAC14 SUPT16H TAOK1 PRKDC EP300 CUX1 | 1.80e-05 | 980 | 38 | 19 | HP:0000177 |
| HumanPheno | Sclerocornea | 2.64e-05 | 49 | 38 | 5 | HP:0000647 | |
| HumanPheno | Aplasia/hypoplasia affecting bones of the axial skeleton | TPM3 ATR CENPF KIF21A CEP290 CPLX1 ARHGEF38 CHD8 UPF3B LBR NEB NXN CREBBP JMJD1C CREB3L1 LETM1 VAC14 SUPT16H EP300 | 2.75e-05 | 1008 | 38 | 19 | HP:0009122 |
| HumanPheno | Abnormal mandible morphology | TPM3 ABAT ATR CENPF KIF21A CEP290 CPLX1 CHD8 UPF3B LBR NEB NXN CREBBP JMJD1C CREB3L1 LETM1 VAC14 SUPT16H SCN9A EP300 | 3.16e-05 | 1118 | 38 | 20 | HP:0000277 |
| HumanPheno | Abnormality of the neck | TPM3 KIF21A CEP290 CPLX1 LBR NEB NXN CREBBP JMJD1C LETM1 BAP1 DNAH1 VAC14 SQSTM1 SUPT16H SCN9A EP300 | 5.09e-05 | 858 | 38 | 17 | HP:0000464 |
| HumanPheno | Plantar crease between first and second toes | 5.42e-05 | 2 | 38 | 2 | HP:0008107 | |
| HumanPheno | Aortic isthmus hypoplasia | 5.42e-05 | 2 | 38 | 2 | HP:0034227 | |
| HumanPheno | High axial triradius | 5.42e-05 | 2 | 38 | 2 | HP:0001042 | |
| HumanPheno | Abnormal lung development | 5.50e-05 | 244 | 38 | 9 | HP:4000059 | |
| HumanPheno | Preaxial foot polydactyly | 6.28e-05 | 30 | 38 | 4 | HP:0001841 | |
| HumanPheno | Tethered cord | 8.15e-05 | 32 | 38 | 4 | HP:0002144 | |
| HumanPheno | Joint dislocation | 8.35e-05 | 390 | 38 | 11 | HP:0001373 | |
| HumanPheno | Abnormal pinna morphology | TPM3 ATR CENPF KIF21A CEP290 CPLX1 CHD8 UPF3B LBR NEB NXN CREBBP JMJD1C LETM1 BAP1 VAC14 SUPT16H TAOK1 PRKDC EP300 CUX1 | 8.39e-05 | 1299 | 38 | 21 | HP:0000377 |
| HumanPheno | Duplication involving bones of the feet | 8.60e-05 | 147 | 38 | 7 | HP:0009136 | |
| HumanPheno | Foot polydactyly | 8.60e-05 | 147 | 38 | 7 | HP:0001829 | |
| HumanPheno | Abnormal conus terminalis morphology | 9.23e-05 | 33 | 38 | 4 | HP:0031938 | |
| HumanPheno | Abnormality of the tubular bones | ATR CEP290 CPLX1 UPF3B LBR NEB NXN CREBBP CREB3L1 LETM1 VAC14 SQSTM1 EP300 RPL13 | 9.82e-05 | 632 | 38 | 14 | HP:0100713 |
| HumanPheno | Abnormality of the long tubular bones | ATR CEP290 CPLX1 UPF3B LBR NEB NXN CREBBP CREB3L1 LETM1 VAC14 SQSTM1 EP300 RPL13 | 9.82e-05 | 632 | 38 | 14 | HP:0100714 |
| HumanPheno | Abnormal sternal ossification | 1.04e-04 | 13 | 38 | 3 | HP:0011863 | |
| HumanPheno | Short upper lip | 1.04e-04 | 13 | 38 | 3 | HP:0000188 | |
| HumanPheno | Abnormal sternum morphology | TPM3 CPLX1 UPF3B LBR NEB NXN CREBBP LETM1 VAC14 UBTF EP300 CUX1 | 1.04e-04 | 474 | 38 | 12 | HP:0000766 |
| HumanPheno | Abnormality of the philtrum | TPM3 CEP290 CPLX1 CHD8 UPF3B NEB NXN CREBBP JMJD1C LETM1 BAP1 VAC14 TAOK1 PRKDC EP300 | 1.11e-04 | 726 | 38 | 15 | HP:0000288 |
| HumanPheno | Slender build | 1.13e-04 | 66 | 38 | 5 | HP:0001533 | |
| HumanPheno | Cleft palate | ATR CENPF KIF21A CEP290 CPLX1 ARHGEF38 LBR NEB NXN CREBBP JMJD1C LETM1 SUPT16H EP300 | 1.19e-04 | 643 | 38 | 14 | HP:0000175 |
| HumanPheno | Abnormal hard palate morphology | ATR CENPF KIF21A CEP290 CPLX1 ARHGEF38 LBR NEB NXN CREBBP JMJD1C LETM1 SUPT16H EP300 | 1.27e-04 | 647 | 38 | 14 | HP:0100737 |
| HumanPheno | Abnormality of globe location | TPM3 CENPF KIF21A CEP290 CPLX1 CHD8 LBR NEB NXN CREBBP JMJD1C LETM1 BAP1 VAC14 SUPT16H TAOK1 PRKDC EP300 CUX1 | 1.30e-04 | 1122 | 38 | 19 | HP:0100886 |
| HumanPheno | Abnormality of the outer ear | TPM3 ATR CENPF KIF21A CEP290 CPLX1 CHD8 UPF3B LBR NEB NXN CREBBP JMJD1C LETM1 BAP1 VAC14 SUPT16H TAOK1 PRKDC EP300 CUX1 | 1.32e-04 | 1337 | 38 | 21 | HP:0000356 |
| HumanPheno | Hypertelorism | TPM3 CENPF KIF21A CEP290 CPLX1 CHD8 LBR NEB NXN CREBBP JMJD1C LETM1 VAC14 SUPT16H TAOK1 EP300 | 1.36e-04 | 830 | 38 | 16 | HP:0000316 |
| HumanPheno | Abnormal epiphysis morphology | 1.56e-04 | 279 | 38 | 9 | HP:0005930 | |
| HumanPheno | Laryngeal cartilage malformation | 1.62e-04 | 3 | 38 | 2 | HP:0008752 | |
| HumanPheno | Phobia | 1.62e-04 | 3 | 38 | 2 | HP:5200232 | |
| HumanPheno | Agoraphobia | 1.62e-04 | 3 | 38 | 2 | HP:0000756 | |
| HumanPheno | Humoral immunodeficiency | 1.62e-04 | 3 | 38 | 2 | HP:0005363 | |
| HumanPheno | Prominent nasal septum | 1.62e-04 | 3 | 38 | 2 | HP:0005322 | |
| HumanPheno | Radial deviation of thumb terminal phalanx | 1.62e-04 | 3 | 38 | 2 | HP:0005895 | |
| HumanPheno | Short hallux | 1.62e-04 | 38 | 38 | 4 | HP:0010109 | |
| HumanPheno | Abnormality of globe location or size | TPM3 ATR CENPF KIF21A CEP290 CPLX1 CHD8 LBR NEB NXN CREBBP JMJD1C LETM1 BAP1 VAC14 SUPT16H TAOK1 PRKDC EP300 CUX1 | 1.63e-04 | 1246 | 38 | 20 | HP:0000489 |
| HumanPheno | Downslanted palpebral fissures | ABAT ATR CEP290 CPLX1 CHD8 NXN CREBBP JMJD1C LETM1 BAP1 SUPT16H EP300 | 1.65e-04 | 497 | 38 | 12 | HP:0000494 |
| HumanPheno | Hydrocephalus | SPAG1 CENPF CEP290 CPLX1 CFAP43 JMJD1C LETM1 BAP1 DNAH1 VAC14 TAOK1 | 1.67e-04 | 421 | 38 | 11 | HP:0000238 |
| HumanPheno | Abnormal neck morphology | TPM3 KIF21A CEP290 CPLX1 LBR NEB NXN CREBBP JMJD1C LETM1 BAP1 VAC14 SQSTM1 SUPT16H EP300 | 2.07e-04 | 766 | 38 | 15 | HP:0025668 |
| HumanPheno | Ventricular septal defect | CEP290 CPLX1 LBR NXN CREBBP JMJD1C LETM1 BAP1 VAC14 TAOK1 EP300 CUX1 | 2.11e-04 | 510 | 38 | 12 | HP:0001629 |
| HumanPheno | Tooth agenesis | ATR CEP290 CPLX1 ARHGEF38 NXN CREBBP CREB3L1 LETM1 EP300 CUX1 | 2.32e-04 | 363 | 38 | 10 | HP:0009804 |
| HumanPheno | Abnormal ventricular septum morphology | CEP290 CPLX1 LBR NXN CREBBP JMJD1C LETM1 BAP1 VAC14 TAOK1 EP300 CUX1 | 2.58e-04 | 521 | 38 | 12 | HP:0010438 |
| HumanPheno | Aplasia/Hypoplasia of the hallux | 2.64e-04 | 43 | 38 | 4 | HP:0008362 | |
| HumanPheno | Orofacial cleft | ATR CENPF KIF21A CEP290 CPLX1 ARHGEF38 LBR NEB NXN CREBBP JMJD1C LETM1 SUPT16H EP300 | 2.72e-04 | 694 | 38 | 14 | HP:0000202 |
| HumanPheno | Craniofacial cleft | ATR CENPF KIF21A CEP290 CPLX1 ARHGEF38 LBR NEB NXN CREBBP JMJD1C LETM1 SUPT16H EP300 | 2.72e-04 | 694 | 38 | 14 | HP:5201015 |
| HumanPheno | Multiple prenatal fractures | 2.89e-04 | 18 | 38 | 3 | HP:0005855 | |
| HumanPheno | Trichiasis | 3.22e-04 | 4 | 38 | 2 | HP:0001128 | |
| HumanPheno | Visceral hemangioma | 3.22e-04 | 4 | 38 | 2 | HP:0410266 | |
| HumanPheno | Talon cusp | 3.22e-04 | 4 | 38 | 2 | HP:0011087 | |
| HumanPheno | Widened distal phalanges | 3.22e-04 | 4 | 38 | 2 | HP:0006200 | |
| HumanPheno | Vascular ring | 3.22e-04 | 4 | 38 | 2 | HP:0010775 | |
| HumanPheno | Hepatic hemangioma | 3.22e-04 | 4 | 38 | 2 | HP:0031207 | |
| HumanPheno | Abnormal palate morphology | TPM3 ATR CENPF KIF21A CEP290 CPLX1 ARHGEF38 UPF3B LBR NEB NXN CREBBP JMJD1C LETM1 BAP1 VAC14 SUPT16H TAOK1 EP300 | 3.41e-04 | 1202 | 38 | 19 | HP:0000174 |
| HumanPheno | Abnormal hallux phalanx morphology | 3.43e-04 | 46 | 38 | 4 | HP:0010057 | |
| HumanPheno | Abnormal neurological laboratory findings | TPM3 SPAG1 CENPF CEP290 CPLX1 CFAP43 NEB NDUFA10 JMJD1C LETM1 BAP1 DNAH1 VAC14 SQSTM1 UBTF SCN9A TAOK1 | 3.65e-04 | 1000 | 38 | 17 | HP:0003129 |
| HumanPheno | Disinhibition | PMS1 ATR CEP290 CHD8 UPF3B CREBBP JMJD1C BAP1 SQSTM1 UBTF SUPT16H SCN9A TAOK1 LNPK EP300 | 3.73e-04 | 807 | 38 | 15 | HP:0000734 |
| HumanPheno | Inappropriate behavior | PMS1 ATR CEP290 CHD8 UPF3B CREBBP JMJD1C BAP1 SQSTM1 UBTF SUPT16H SCN9A TAOK1 LNPK EP300 | 3.73e-04 | 807 | 38 | 15 | HP:0000719 |
| HumanPheno | Abnormal response to social norms | PMS1 ATR CEP290 CHD8 UPF3B CREBBP JMJD1C BAP1 SQSTM1 UBTF SUPT16H SCN9A TAOK1 LNPK EP300 | 3.73e-04 | 807 | 38 | 15 | HP:5200123 |
| HumanPheno | Social disinhibition | PMS1 ATR CEP290 CHD8 UPF3B CREBBP JMJD1C BAP1 SQSTM1 UBTF SUPT16H SCN9A TAOK1 LNPK EP300 | 3.73e-04 | 807 | 38 | 15 | HP:5200029 |
| HumanPheno | Abnormal superior vena cava morphology | 3.74e-04 | 85 | 38 | 5 | HP:0025575 | |
| HumanPheno | Clumsiness | 3.95e-04 | 86 | 38 | 5 | HP:0002312 | |
| HumanPheno | Absent earlobe | 4.00e-04 | 20 | 38 | 3 | HP:0000387 | |
| HumanPheno | Ocular pain | 4.00e-04 | 20 | 38 | 3 | HP:0200026 | |
| HumanPheno | Abnormal curvature of the vertebral column | TPM3 ATR KIF21A CEP290 CPLX1 UPF3B LBR NEB NXN CREBBP JMJD1C LETM1 BAP1 VAC14 UBTF SUPT16H SCN9A EP300 RPL13 | 4.14e-04 | 1219 | 38 | 19 | HP:0010674 |
| HumanPheno | Abnormality of habitus | 4.17e-04 | 87 | 38 | 5 | HP:0010718 | |
| HumanPheno | Lower extremity joint dislocation | 4.17e-04 | 318 | 38 | 9 | HP:0030311 | |
| HumanPheno | Abnormal vena cava morphology | 4.40e-04 | 88 | 38 | 5 | HP:0030971 | |
| HumanPheno | Short philtrum | 4.42e-04 | 253 | 38 | 8 | HP:0000322 | |
| HumanPheno | Abnormal long bone morphology | ATR CEP290 CPLX1 UPF3B LBR NEB NXN CREBBP CREB3L1 LETM1 VAC14 SQSTM1 SCN9A EP300 RPL13 | 4.51e-04 | 821 | 38 | 15 | HP:0011314 |
| HumanPheno | Abnormal vena cava morphology | 4.63e-04 | 89 | 38 | 5 | HP:0005345 | |
| HumanPheno | Hypoplasia of the toes | 4.74e-04 | 50 | 38 | 4 | HP:0004701 | |
| HumanPheno | Abnormal limb epiphysis morphology | 4.79e-04 | 138 | 38 | 6 | HP:0006505 | |
| HumanPheno | Aplasia/hypoplasia involving the skeleton | TPM3 ATR CENPF KIF21A CEP290 CPLX1 ARHGEF38 CHD8 UPF3B LBR NEB NXN CREBBP JMJD1C CREB3L1 LETM1 VAC14 SUPT16H EP300 RPL13 | 4.84e-04 | 1343 | 38 | 20 | HP:0009115 |
| HumanPheno | Hyperactivity | PMS1 ATR CHD8 UPF3B CREBBP JMJD1C BAP1 UBTF SUPT16H TAOK1 LNPK EP300 | 4.91e-04 | 558 | 38 | 12 | HP:0000752 |
| HumanPheno | Abnormality of the palmar creases | 5.31e-04 | 260 | 38 | 8 | HP:0010490 | |
| HumanPheno | Papillary cystadenoma of the epididymis | 5.34e-04 | 5 | 38 | 2 | HP:0009715 | |
| HumanPheno | Patchy changes of bone mineral density | 5.34e-04 | 5 | 38 | 2 | HP:0010658 | |
| HumanPheno | Supernumerary cusp | 5.34e-04 | 5 | 38 | 2 | HP:0033777 | |
| HumanPheno | Epididymal neoplasm | 5.34e-04 | 5 | 38 | 2 | HP:0030421 | |
| HumanPheno | Abnormal hip bone morphology | TPM3 ATR CPLX1 LBR NEB NXN CREBBP LETM1 BAP1 VAC14 SCN9A EP300 RPL13 | 5.62e-04 | 653 | 38 | 13 | HP:0003272 |
| HumanPheno | Abnormal lip morphology | TPM3 CEP290 CPLX1 ARHGEF38 CHD8 UPF3B LBR NEB NXN CREBBP JMJD1C LETM1 BAP1 VAC14 SUPT16H TAOK1 PRKDC EP300 CUX1 | 5.75e-04 | 1249 | 38 | 19 | HP:0000159 |
| HumanPheno | Aplasia/Hypoplasia of the earlobes | 5.93e-04 | 53 | 38 | 4 | HP:0009906 | |
| HumanPheno | Dental crowding | 6.01e-04 | 144 | 38 | 6 | HP:0000678 | |
| HumanPheno | Abnormal palmar dermatoglyphics | 6.03e-04 | 265 | 38 | 8 | HP:0001018 | |
| HumanPheno | Abnormal calvaria morphology | ATR KIF21A CEP290 CPLX1 UPF3B LBR NEB NXN CREBBP JMJD1C CREB3L1 LETM1 BAP1 VAC14 SUPT16H SCN9A TAOK1 EP300 CUX1 | 6.07e-04 | 1254 | 38 | 19 | HP:0002683 |
| HumanPheno | Abnormal foramen magnum morphology | 6.12e-04 | 23 | 38 | 3 | HP:0002699 | |
| HumanPheno | Convex nasal ridge | 6.26e-04 | 95 | 38 | 5 | HP:0000444 | |
| MousePheno | enlarged stomach | ANKRD20A3P ANKRD20A8P ANKRD18B ANKRD20A4P ANKRD18A ANKRD20A1 | 8.54e-08 | 33 | 96 | 6 | MP:0003883 |
| MousePheno | abnormal digestive system morphology | INPP5D KIF16B SHOX2 GBP2 CHD8 UPF3B ANKRD20A3P ANKRD20A8P NXN CREBBP KIF20B ANKRD18B BAP1 DDX10 ANKRD20A4P BAZ1A SQSTM1 ANKRD18A PRKDC EP300 ANKRD20A1 GOLGB1 | 2.41e-05 | 1233 | 96 | 22 | MP:0000462 |
| MousePheno | abnormal stomach morphology | UPF3B ANKRD20A3P ANKRD20A8P ANKRD18B ANKRD20A4P BAZ1A SQSTM1 ANKRD18A ANKRD20A1 | 5.10e-05 | 248 | 96 | 9 | MP:0000470 |
| MousePheno | abnormal sternum morphology | UPF3B ANKRD20A3P ANKRD20A8P NXN CREBBP ANKRD18B ANKRD20A4P ANKRD18A ANKRD20A1 | 6.32e-05 | 255 | 96 | 9 | MP:0000157 |
| Domain | Ank_2 | SHANK1 UACA POTEF ANKRD30B ANKRD20A2P ANKRD20A3P ASAP1 POTEE ANKRD20A4P ANKRD18A ANKRD20A1 | 2.95e-07 | 215 | 129 | 11 | PF12796 |
| Domain | Ank | SHANK1 UACA POTEF ANKRD30B ANKRD20A2P ANKRD20A3P ASAP1 POTEE ANKRD20A4P ANKRD18A ANKRD20A1 | 5.30e-07 | 228 | 129 | 11 | PF00023 |
| Domain | - | SHANK1 UACA POTEF ANKRD30B ANKRD20A2P ANKRD20A3P ASAP1 POTEE ANKRD20A4P ANKRD18A ANKRD20A1 | 1.21e-06 | 248 | 129 | 11 | 1.25.40.20 |
| Domain | ANK | SHANK1 UACA POTEF ANKRD30B ANKRD20A2P ANKRD20A3P ASAP1 POTEE ANKRD20A4P ANKRD18A ANKRD20A1 | 1.37e-06 | 251 | 129 | 11 | SM00248 |
| Domain | ANK_REPEAT | SHANK1 UACA POTEF ANKRD30B ANKRD20A2P ANKRD20A3P ASAP1 POTEE ANKRD20A4P ANKRD18A ANKRD20A1 | 1.48e-06 | 253 | 129 | 11 | PS50088 |
| Domain | Ankyrin_rpt-contain_dom | SHANK1 UACA POTEF ANKRD30B ANKRD20A2P ANKRD20A3P ASAP1 POTEE ANKRD20A4P ANKRD18A ANKRD20A1 | 1.53e-06 | 254 | 129 | 11 | IPR020683 |
| Domain | ANK_REP_REGION | SHANK1 UACA POTEF ANKRD30B ANKRD20A2P ANKRD20A3P ASAP1 POTEE ANKRD20A4P ANKRD18A ANKRD20A1 | 1.53e-06 | 254 | 129 | 11 | PS50297 |
| Domain | Ankyrin_rpt | SHANK1 UACA POTEF ANKRD30B ANKRD20A2P ANKRD20A3P ASAP1 POTEE ANKRD20A4P ANKRD18A ANKRD20A1 | 2.07e-06 | 262 | 129 | 11 | IPR002110 |
| Domain | Prefoldin | 1.04e-05 | 72 | 129 | 6 | IPR009053 | |
| Domain | Nuc_rcpt_coact_CREBbp | 4.73e-05 | 2 | 129 | 2 | IPR014744 | |
| Domain | ZnF_TAZ | 4.73e-05 | 2 | 129 | 2 | SM00551 | |
| Domain | - | 4.73e-05 | 2 | 129 | 2 | 1.20.1020.10 | |
| Domain | RING_CBP-p300 | 4.73e-05 | 2 | 129 | 2 | IPR010303 | |
| Domain | - | 4.73e-05 | 2 | 129 | 2 | 1.10.1630.10 | |
| Domain | Creb_binding | 4.73e-05 | 2 | 129 | 2 | PF09030 | |
| Domain | zf-TAZ | 4.73e-05 | 2 | 129 | 2 | PF02135 | |
| Domain | ZF_TAZ | 4.73e-05 | 2 | 129 | 2 | PS50134 | |
| Domain | KAT11 | 4.73e-05 | 2 | 129 | 2 | SM01250 | |
| Domain | Znf_TAZ | 4.73e-05 | 2 | 129 | 2 | IPR000197 | |
| Domain | KIX | 4.73e-05 | 2 | 129 | 2 | PF02172 | |
| Domain | HAT_KAT11 | 4.73e-05 | 2 | 129 | 2 | PF08214 | |
| Domain | KIX | 4.73e-05 | 2 | 129 | 2 | PS50952 | |
| Domain | CBP_P300_HAT | 4.73e-05 | 2 | 129 | 2 | IPR031162 | |
| Domain | DUF902 | 4.73e-05 | 2 | 129 | 2 | PF06001 | |
| Domain | - | 4.73e-05 | 2 | 129 | 2 | 1.10.246.20 | |
| Domain | Histone_AcTrfase_Rtt109/CBP | 4.73e-05 | 2 | 129 | 2 | IPR013178 | |
| Domain | KIX_dom | 4.73e-05 | 2 | 129 | 2 | IPR003101 | |
| Domain | CBP_P300_HAT | 4.73e-05 | 2 | 129 | 2 | PS51727 | |
| Domain | SH3 | 1.29e-04 | 216 | 129 | 8 | SM00326 | |
| Domain | SH3 | 1.29e-04 | 216 | 129 | 8 | PS50002 | |
| Domain | AFAP | 1.41e-04 | 3 | 129 | 2 | IPR030113 | |
| Domain | SH3_domain | 1.47e-04 | 220 | 129 | 8 | IPR001452 | |
| Domain | SH3_9 | 2.05e-04 | 78 | 129 | 5 | PF14604 | |
| Domain | ZF_ZZ_2 | 2.43e-04 | 18 | 129 | 3 | PS50135 | |
| Domain | ZF_ZZ_1 | 2.43e-04 | 18 | 129 | 3 | PS01357 | |
| Domain | ZZ | 2.43e-04 | 18 | 129 | 3 | PF00569 | |
| Domain | Znf_ZZ | 2.88e-04 | 19 | 129 | 3 | IPR000433 | |
| Domain | ZnF_ZZ | 2.88e-04 | 19 | 129 | 3 | SM00291 | |
| Domain | ZnF_Rad18 | 4.67e-04 | 5 | 129 | 2 | SM00734 | |
| Domain | FATC | 4.67e-04 | 5 | 129 | 2 | PF02260 | |
| Domain | Znf_Rad18_put | 4.67e-04 | 5 | 129 | 2 | IPR006642 | |
| Domain | HEAT | 6.91e-04 | 58 | 129 | 4 | IPR000357 | |
| Domain | Nuc_rcpt_coact | 6.97e-04 | 6 | 129 | 2 | IPR009110 | |
| Domain | FAT | 6.97e-04 | 6 | 129 | 2 | PS51189 | |
| Domain | FATC | 6.97e-04 | 6 | 129 | 2 | PS51190 | |
| Domain | FAT | 6.97e-04 | 6 | 129 | 2 | PF02259 | |
| Domain | PIK-rel_kinase_FAT | 6.97e-04 | 6 | 129 | 2 | IPR003151 | |
| Domain | FATC_dom | 6.97e-04 | 6 | 129 | 2 | IPR003152 | |
| Domain | PIK_FAT | 6.97e-04 | 6 | 129 | 2 | IPR014009 | |
| Domain | FATC | 6.97e-04 | 6 | 129 | 2 | SM01343 | |
| Domain | Bromodomain_CS | 7.45e-04 | 26 | 129 | 3 | IPR018359 | |
| Domain | AH/BAR-dom | 1.14e-03 | 30 | 129 | 3 | IPR027267 | |
| Domain | - | 1.14e-03 | 30 | 129 | 3 | 1.20.1270.60 | |
| Domain | HEAT_REPEAT | 1.40e-03 | 70 | 129 | 4 | PS50077 | |
| Domain | Ataxin-2_C | 1.65e-03 | 9 | 129 | 2 | IPR009818 | |
| Domain | PAM2 | 1.65e-03 | 9 | 129 | 2 | PF07145 | |
| Domain | - | 2.05e-03 | 10 | 129 | 2 | 1.10.220.60 | |
| Domain | BROMODOMAIN_1 | 2.11e-03 | 37 | 129 | 3 | PS00633 | |
| Domain | Bromodomain | 2.28e-03 | 38 | 129 | 3 | PF00439 | |
| Domain | Grip | 2.50e-03 | 11 | 129 | 2 | SM00755 | |
| Domain | GRIP | 2.50e-03 | 11 | 129 | 2 | PF01465 | |
| Domain | Kinesin_motor_CS | 2.83e-03 | 41 | 129 | 3 | IPR019821 | |
| Domain | BROMODOMAIN_2 | 2.83e-03 | 41 | 129 | 3 | PS50014 | |
| Domain | SH3_2 | 2.98e-03 | 86 | 129 | 4 | PF07653 | |
| Domain | SH3_2 | 2.98e-03 | 86 | 129 | 4 | IPR011511 | |
| Domain | GRIP_dom | 2.99e-03 | 12 | 129 | 2 | IPR000237 | |
| Domain | GRIP | 2.99e-03 | 12 | 129 | 2 | PS50913 | |
| Domain | Bromodomain | 3.04e-03 | 42 | 129 | 3 | IPR001487 | |
| Domain | BROMO | 3.04e-03 | 42 | 129 | 3 | SM00297 | |
| Domain | - | 3.04e-03 | 42 | 129 | 3 | 1.20.920.10 | |
| Domain | Kinesin-like_fam | 3.25e-03 | 43 | 129 | 3 | IPR027640 | |
| Domain | - | 3.47e-03 | 44 | 129 | 3 | 3.40.850.10 | |
| Domain | Kinesin | 3.47e-03 | 44 | 129 | 3 | PF00225 | |
| Domain | KISc | 3.47e-03 | 44 | 129 | 3 | SM00129 | |
| Domain | KINESIN_MOTOR_1 | 3.47e-03 | 44 | 129 | 3 | PS00411 | |
| Domain | Kinesin_motor_dom | 3.47e-03 | 44 | 129 | 3 | IPR001752 | |
| Domain | KINESIN_MOTOR_2 | 3.47e-03 | 44 | 129 | 3 | PS50067 | |
| Domain | HEAT | 4.44e-03 | 48 | 129 | 3 | PF02985 | |
| Domain | BAR | 4.69e-03 | 15 | 129 | 2 | SM00721 | |
| Domain | PI3/4_kinase_CS | 4.69e-03 | 15 | 129 | 2 | IPR018936 | |
| Domain | - | 5.33e-03 | 16 | 129 | 2 | 1.10.1070.11 | |
| Domain | BAR_dom | 5.33e-03 | 16 | 129 | 2 | IPR004148 | |
| Domain | PI3Kc | 5.33e-03 | 16 | 129 | 2 | SM00146 | |
| Domain | Actin_CS | 5.33e-03 | 16 | 129 | 2 | IPR004001 | |
| Domain | SH3_1 | 5.64e-03 | 164 | 129 | 5 | PF00018 | |
| Domain | HMG_box | 5.86e-03 | 53 | 129 | 3 | PF00505 | |
| Domain | ACTINS_2 | 6.02e-03 | 17 | 129 | 2 | PS00432 | |
| Domain | HMG_BOX_2 | 6.18e-03 | 54 | 129 | 3 | PS50118 | |
| Domain | HMG | 6.18e-03 | 54 | 129 | 3 | SM00398 | |
| Domain | - | 6.50e-03 | 55 | 129 | 3 | 1.10.30.10 | |
| Domain | PI3_PI4_kinase | 6.74e-03 | 18 | 129 | 2 | PF00454 | |
| Domain | PI3_4_KINASE_1 | 6.74e-03 | 18 | 129 | 2 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 6.74e-03 | 18 | 129 | 2 | PS00916 | |
| Domain | PI3/4_kinase_cat_dom | 6.74e-03 | 18 | 129 | 2 | IPR000403 | |
| Domain | PI3_4_KINASE_3 | 6.74e-03 | 18 | 129 | 2 | PS50290 | |
| Domain | Actin/actin-like_CS | 6.74e-03 | 18 | 129 | 2 | IPR020902 | |
| Pathway | BIOCARTA_G2_PATHWAY | 9.52e-06 | 22 | 88 | 4 | MM1365 | |
| Pathway | BIOCARTA_G2_PATHWAY | 1.37e-05 | 24 | 88 | 4 | M8560 | |
| Pathway | REACTOME_PI_METABOLISM | 1.17e-04 | 77 | 88 | 5 | MM14590 | |
| Pathway | REACTOME_PI_METABOLISM | 1.77e-04 | 84 | 88 | 5 | M676 | |
| Pathway | WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY | 1.89e-04 | 46 | 88 | 4 | M48317 | |
| Pathway | WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS | 1.98e-04 | 86 | 88 | 5 | M39375 | |
| Pathway | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE | 2.62e-04 | 50 | 88 | 4 | MM14641 | |
| Pathway | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE | 3.29e-04 | 53 | 88 | 4 | M662 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 3.32e-04 | 22 | 88 | 3 | MM1370 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 3.81e-04 | 5 | 88 | 2 | MM1575 | |
| Pathway | REACTOME_NFE2L2_REGULATING_INFLAMMATION_ASSOCIATED_GENES | 3.81e-04 | 5 | 88 | 2 | M48020 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ER_STRESS_ASSOCIATED_GENES | 3.81e-04 | 5 | 88 | 2 | M48023 | |
| Pathway | REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION | 3.81e-04 | 5 | 88 | 2 | M27228 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 4.33e-04 | 24 | 88 | 3 | M13404 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | DOCK1 TPM3 FNBP1 UACA CENPF ITSN1 NUF2 LBR YWHAH LETM1 POTEE NDC80 TAOK1 | 5.01e-04 | 720 | 88 | 13 | M41838 |
| Pathway | BIOCARTA_PELP1_PATHWAY | 5.69e-04 | 6 | 88 | 2 | M22062 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 7.18e-04 | 65 | 88 | 4 | M39682 | |
| Pathway | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | 7.87e-04 | 116 | 88 | 5 | MM15715 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 7.93e-04 | 7 | 88 | 2 | MM1573 | |
| Pathway | PID_RETINOIC_ACID_PATHWAY | 8.45e-04 | 30 | 88 | 3 | M207 | |
| Pathway | REACTOME_RHOG_GTPASE_CYCLE | 1.00e-03 | 71 | 88 | 4 | MM15604 | |
| Pathway | BIOCARTA_PLK3_PATHWAY | 1.05e-03 | 8 | 88 | 2 | M22021 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 1.05e-03 | 8 | 88 | 2 | M22058 | |
| Pathway | REACTOME_NFE2L2_REGULATING_MDR_ASSOCIATED_ENZYMES | 1.05e-03 | 8 | 88 | 2 | M48022 | |
| Pathway | REACTOME_REGULATION_OF_NFE2L2_GENE_EXPRESSION | 1.05e-03 | 8 | 88 | 2 | M48024 | |
| Pathway | REACTOME_NFE2L2_REGULATES_PENTOSE_PHOSPHATE_PATHWAY_GENES | 1.05e-03 | 8 | 88 | 2 | M46443 | |
| Pathway | KEGG_CELL_CYCLE | 1.10e-03 | 125 | 88 | 5 | M7963 | |
| Pathway | REACTOME_RHOG_GTPASE_CYCLE | 1.17e-03 | 74 | 88 | 4 | M41814 | |
| Pathway | WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA | 1.22e-03 | 34 | 88 | 3 | M39771 | |
| Pathway | REACTOME_PI5P_REGULATES_TP53_ACETYLATION | 1.35e-03 | 9 | 88 | 2 | MM15357 | |
| Pathway | REACTOME_PI5P_REGULATES_TP53_ACETYLATION | 1.35e-03 | 9 | 88 | 2 | M27655 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR3_IRF3_SIGNALING_PATHWAY | 1.35e-03 | 9 | 88 | 2 | M47451 | |
| Pubmed | Expression of testicular germ cell genes identified by differential display analysis. | ANKRD20A3P ANKRD20A8P ANKRD18B ANKRD20A4P ANKRD18A ANKRD20A1 | 8.90e-14 | 8 | 136 | 6 | 12634303 |
| Pubmed | TPM3 RAD18 ZC3H13 CHD8 FAM133B MRPS7 SCAF1 MFAP1 PAXBP1 SUPT16H SCAF11 PRKDC PIP4K2C CPSF2 | 1.41e-12 | 251 | 136 | 14 | 31076518 | |
| Pubmed | TPM3 MACC1 SPAG1 CENPF POTEF KIF21A ITSN1 CPLX1 MRPS35 ANKRD30B MYO1B CAGE1 NEB YWHAH LETM1 PPL FAM133B POTEE MFAP1 GRPEL1 GSPT2 BAZ1A SUPT16H SCN9A PRKDC CUX1 GOLGB1 RPL13 | 1.84e-12 | 1442 | 136 | 28 | 35575683 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | TPM3 UACA CENPF ZC3H13 MRPS35 MYO1B NDUFA10 YWHAH KIF20B THOC5 PPL LACTB AFAP1L1 MRPS7 MFAP1 KIN SQSTM1 UBTF KIAA1217 SUPT16H EIF5 SCAF11 PRKDC TACSTD2 RPL13 LRRFIP2 | 3.17e-12 | 1257 | 136 | 26 | 36526897 |
| Pubmed | TPM3 MACC1 SUPT20H GIPC2 UACA HMGXB4 MRPS35 CDK11A CHD8 URB2 NDUFA10 KIF20B DDX10 FAM133B POTEE MRPS7 SCAF1 PAXBP1 BAZ1A SQSTM1 EIF5 HELZ SCAF11 DNAJC1 CPSF2 TACSTD2 MNAT1 GOLGB1 | 4.46e-12 | 1497 | 136 | 28 | 31527615 | |
| Pubmed | SHANK1 DOCK1 SUPT20H ITSN1 CEP290 CHD8 CCDC92 NEB CREBBP YWHAH ASAP1 HELZ PRKDC TXLNG EP300 CUX1 GOLGB1 | 8.98e-12 | 486 | 136 | 17 | 20936779 | |
| Pubmed | PMS1 UACA MAP2 ZC3H13 ITSN1 KIF16B MRPS35 LBR PRPF40A LETM1 THOC5 ADD2 LACTB DDX10 MRPS7 MFAP1 GRPEL1 PAXBP1 UBTF SUPT16H DNAJC1 LNPK TXLNG CUX1 GOLGA4 GOLGB1 RPL13 | 2.24e-11 | 1487 | 136 | 27 | 33957083 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | TPM3 FNBP1 RAD18 ATR UACA ZC3H13 ITSN1 CDK11A PRPF40A PPL BAP1 SCAF1 MFAP1 PAXBP1 HELZ TAOK1 SCAF11 PRKDC CPSF2 GOLGA4 | 2.75e-11 | 774 | 136 | 20 | 15302935 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | RAD18 SUPT20H ATR CENPF ZC3H13 CEP290 HMGXB4 LBR PRPF40A JMJD1C THOC5 BAP1 SCAF1 MFAP1 PAXBP1 BAZ1A UBTF SUPT16H SCAF11 DNAJC1 PRKDC CPSF2 EP300 CUX1 RPL13 | 3.75e-11 | 1294 | 136 | 25 | 30804502 |
| Pubmed | TPM3 RAD18 SUPT20H LRRC49 HMGXB4 MRPS35 CDK11A MYO1B CHD8 LBR CREBBP PRPF40A YWHAH JMJD1C BAP1 DDX10 MRPS7 MFAP1 GRPEL1 SQSTM1 UBTF HELZ SCAF11 CPSF2 EP300 CUX1 | 5.34e-11 | 1429 | 136 | 26 | 35140242 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | PMS1 RAD18 ZC3H13 HMGXB4 CDK11A CHD8 LBR NDUFA10 PRPF40A JMJD1C KIF20B DDX10 MFAP1 PAXBP1 BAZ1A UBTF SUPT16H EIF5 SCAF11 PRKDC CUX1 | 1.60e-10 | 954 | 136 | 21 | 36373674 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | TPM3 HSP90AB4P ATR CENPF MRPS35 MYO1B UPF3B URB2 LBR NDUFA10 PRPF40A LETM1 DDX10 SCAF1 PAXBP1 BAZ1A AMOT SQSTM1 UBTF SUPT16H EIF5 PRKDC GOLGA4 RPL13 LRRFIP2 | 2.82e-10 | 1425 | 136 | 25 | 30948266 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | RAD18 SUPT20H ITSN1 CDK11A MYO1B UPF3B CREBBP KIF20B POTEE ODF2L NDC80 SQSTM1 KIAA1217 HELZ PIP4K2C GOLGB1 | 1.47e-09 | 588 | 136 | 16 | 38580884 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | TPM3 CENPF CEP290 MYO1B URB2 LBR PRPF40A YWHAH DDX10 SCAF1 MFAP1 BAZ1A AMOT SQSTM1 UBTF SUPT16H PRKDC CPSF2 GOLGB1 RPL13 | 3.51e-09 | 1024 | 136 | 20 | 24711643 |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | TPM3 HSP90AB4P ZC3H13 KIF21A NUF2 UPF3B PRPF40A YWHAH NDC80 KIAA1217 RABGAP1L EIF5 EXOG PRKDC PIP4K2C TXLNG GOLGB1 RPL13 | 6.30e-09 | 847 | 136 | 18 | 35235311 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | TPM3 ZC3H13 MRPS35 CHD8 LBR NDUFA10 PRPF40A ADD2 BAP1 DDX10 FAM133B MRPS7 SCAF1 MFAP1 PAXBP1 SUPT16H HELZ TAOK1 PRKDC PIP4K2C CPSF2 RPL13 | 9.33e-09 | 1318 | 136 | 22 | 30463901 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | TPM3 CENPF LRRC49 KIF16B MRPS35 NUF2 UPF3B LBR YWHAH LETM1 LACTB POTEE MRPS7 GRPEL1 NDC80 SQSTM1 KIAA1217 SUPT16H EXOG DNAJC1 LNPK CUX1 GOLGB1 | 1.89e-08 | 1496 | 136 | 23 | 32877691 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | CENPF UPF3B URB2 KIF20B DDX10 FAM133B MRPS7 KIN BAZ1A UBTF SUPT16H SCAF11 PRKDC TXLNG RPL13 LRRFIP2 | 5.21e-08 | 759 | 136 | 16 | 35915203 |
| Pubmed | p300/CREB-binding protein interacts with ATR and is required for the DNA replication checkpoint. | 5.85e-08 | 3 | 136 | 3 | 17272271 | |
| Pubmed | 7.08e-08 | 54 | 136 | 6 | 22266860 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | TPM3 KIF21A MYO1B CHD8 URB2 LBR CREBBP KIF20B ASAP1 DDX10 MRPS7 MFAP1 BAZ1A SQSTM1 UBTF SUPT16H DDX60L PRKDC PIP4K2C GOLGA4 RPL13 | 7.22e-08 | 1353 | 136 | 21 | 29467282 |
| Pubmed | TPM3 UACA MYO1B UPF3B LBR NDUFA10 PRPF40A THOC5 LACTB DDX10 SCAF1 MFAP1 GRPEL1 PAXBP1 BAZ1A SQSTM1 SUPT16H TAOK1 SCAF11 CPSF2 LRRFIP2 | 9.01e-08 | 1371 | 136 | 21 | 36244648 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | ZC3H13 MRPS35 UPF3B LBR PRPF40A DDX10 FAM133B MRPS7 MFAP1 GSPT2 UBTF SUPT16H EIF5 HELZ SCAF11 PRKDC | 1.20e-07 | 807 | 136 | 16 | 22681889 |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | ZC3H13 MYO1B PRPF40A DDX10 MFAP1 PAXBP1 BAZ1A UBTF SUPT16H SCAF11 PRKDC CPSF2 CUX1 RPL13 | 1.22e-07 | 605 | 136 | 14 | 28977666 |
| Pubmed | SHANK1 UACA CENPF KIF21A ITSN1 CHD8 YWHAH LETM1 KIAA1217 SUPT16H EXOG PIP4K2C CPSF2 CUX1 GOLGA4 GOLGB1 LRRFIP2 | 2.43e-07 | 963 | 136 | 17 | 28671696 | |
| Pubmed | KLHL6 FNBP1 RAD18 ZC3H13 ITSN1 LETM1 ASAP1 MTMR6 PAXBP1 KIN BAZ1A AMOT SQSTM1 UBTF TAOK1 LNPK CPSF2 GOLGB1 | 2.56e-07 | 1084 | 136 | 18 | 11544199 | |
| Pubmed | SUPT20H CEP290 CDK11A UPF3B CREBBP ODF2L NDC80 AMOT SQSTM1 SUPT16H PIP4K2C MNAT1 TXLNG EP300 | 2.64e-07 | 645 | 136 | 14 | 25281560 | |
| Pubmed | CENPF ITSN1 HMGXB4 CHD8 LBR ASAP1 BAZ1A PIP4K2C CPSF2 MNAT1 CUX1 GOLGA4 | 3.77e-07 | 472 | 136 | 12 | 38943005 | |
| Pubmed | TPM3 ATR CDK11A MYO1B NUF2 YWHAH FAM133B NDC80 SQSTM1 SUPT16H PRKDC | 5.61e-07 | 401 | 136 | 11 | 25852190 | |
| Pubmed | KLHL6 CENPF ITSN1 CHD8 URB2 CREBBP LETM1 SUPT16H PRKDC EP300 | 8.06e-07 | 332 | 136 | 10 | 37433992 | |
| Pubmed | CENPF LRRC49 CHD8 NDUFA10 JMJD1C KIF20B BAP1 AMOT SQSTM1 CUX1 GOLGB1 | 8.42e-07 | 418 | 136 | 11 | 34709266 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | PMS1 RAD18 HMGXB4 CHD8 JMJD1C KIF20B BAP1 DDX10 BAZ1A UBTF SUPT16H SCAF11 CUX1 | 8.53e-07 | 608 | 136 | 13 | 36089195 |
| Pubmed | 1.02e-06 | 263 | 136 | 9 | 34702444 | ||
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | TPM3 UACA ITSN1 MYO1B YWHAH SQSTM1 UBTF KIAA1217 SUPT16H PRKDC TXLNG CUX1 LRRFIP2 | 1.18e-06 | 626 | 136 | 13 | 33644029 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | CENPF ZC3H13 KIF21A ITSN1 CEP290 ANKRD20A3P POTEE SCAF1 AFAP1L2 AMOT ANKRD18A PRKDC CFAP57 LRRFIP2 | 1.26e-06 | 736 | 136 | 14 | 29676528 |
| Pubmed | DOCK1 FNBP1 YWHAH XIRP2 AMOT SQSTM1 RABGAP1L SUPT16H EIF5 TAOK1 PRKDC | 1.30e-06 | 437 | 136 | 11 | 20562859 | |
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | SPAG1 UACA ZC3H13 MYO1B CREBBP PRPF40A KIAA1217 SUPT16H RPL13 LRRFIP2 | 1.71e-06 | 361 | 136 | 10 | 30344098 |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | ZC3H13 HMGXB4 UPF3B LBR JMJD1C SCAF1 VAC14 BAZ1A PRKDC RPL13 | 1.71e-06 | 361 | 136 | 10 | 26167880 |
| Pubmed | TPM3 RAD18 SUPT20H UACA HMGXB4 CHD8 LBR CREBBP PRPF40A YWHAH SCAF1 MFAP1 SQSTM1 SUPT16H HELZ PIP4K2C EP300 | 1.83e-06 | 1116 | 136 | 17 | 31753913 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 1.87e-06 | 283 | 136 | 9 | 30585729 | |
| Pubmed | Receptor-mediated clustering of FIP200 bypasses the role of LC3 lipidation in autophagy. | URB2 LBR LETM1 BAP1 DDX10 GRPEL1 SQSTM1 UBTF EIF5 EP300 RPL13 | 1.87e-06 | 454 | 136 | 11 | 33226137 |
| Pubmed | 1.88e-06 | 210 | 136 | 8 | 16565220 | ||
| Pubmed | TPM3 UACA KIF21A MYO1B UPF3B LBR NDUFA10 PRPF40A YWHAH THOC5 DNAH1 PAXBP1 GSPT2 SQSTM1 PRKDC CUX1 RPL13 LRRFIP2 | 1.90e-06 | 1247 | 136 | 18 | 27684187 | |
| Pubmed | A unique SUMO-2-interacting motif within LANA is essential for KSHV latency. | 2.02e-06 | 7 | 136 | 3 | 24278015 | |
| Pubmed | The RNA-binding protein HuR is a novel target of Pirh2 E3 ubiquitin ligase. | 2.65e-06 | 220 | 136 | 8 | 34091597 | |
| Pubmed | UACA POTEF MRPS35 CDK11A CHD8 LBR YWHAH POTEE MRPS7 MFAP1 AMOT UBTF RABGAP1L SUPT16H EXOG PRKDC RPL13 | 2.84e-06 | 1153 | 136 | 17 | 29845934 | |
| Pubmed | SHANK1 SUPT20H KIF21A ITSN1 CEP290 MRPS35 NDUFA10 CREBBP YWHAH FAN1 ODF2L TAOK1 PRKDC MNAT1 TXLNG EP300 CUX1 RPL13 | 2.89e-06 | 1285 | 136 | 18 | 35914814 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | RAD18 UACA CENPF CETN3 MRPS35 NUF2 PPL BAP1 MRPS7 ODF2L PAXBP1 KIN NDC80 SQSTM1 ZNF566 PRKDC LRRFIP2 | 2.90e-06 | 1155 | 136 | 17 | 20360068 |
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | TPM3 UACA POTEF MYO1B LBR LACTB POTEE GSPT2 EIF5 GOLGB1 RPL13 LRRFIP2 | 3.21e-06 | 580 | 136 | 12 | 35676659 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | DOCK1 RAD18 ATR KIF21A CHD8 NUF2 PRPF40A NDC80 TAOK1 PRKDC CPSF2 GOLGB1 | 3.33e-06 | 582 | 136 | 12 | 20467437 |
| Pubmed | TPM3 SUPT20H CEP290 MRPS35 LBR KIF20B LETM1 THOC5 LACTB AFAP1L1 AFAP1L2 EIF5 TAOK1 | 3.37e-06 | 689 | 136 | 13 | 36543142 | |
| Pubmed | PMS1 CEP290 MYO1B YWHAH LETM1 ADD2 ASAP1 FAN1 GRPEL1 MTMR6 UBTF SUPT16H HELZ CPSF2 GOLGA4 RPL13 | 3.71e-06 | 1049 | 136 | 16 | 27880917 | |
| Pubmed | TPM3 UACA CDK11A MYO1B LBR MRPS7 UBTF SUPT16H TAOK1 SCAF11 PRKDC RPL13 | 4.61e-06 | 601 | 136 | 12 | 33658012 | |
| Pubmed | GIPC2 MRPS35 LBR NXN POTEE MRPS7 SUPT16H EIF5 DDX60L PRKDC CPSF2 GOLGB1 RPL13 | 4.73e-06 | 711 | 136 | 13 | 33022573 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | SHANK1 RAD18 CHD8 URB2 LBR PRPF40A JMJD1C LETM1 NDC80 AMOT SQSTM1 ZNF566 DNAJC1 PRKDC LNPK GOLGB1 RPL13 | 4.98e-06 | 1203 | 136 | 17 | 29180619 |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | TPM3 UACA CDK11A MYO1B UPF3B PRPF40A DDX10 FAM133B GSPT2 SQSTM1 UBTF SUPT16H PRKDC RPL13 LRRFIP2 | 4.98e-06 | 949 | 136 | 15 | 36574265 |
| Pubmed | Intersectin (ITSN) family of scaffolds function as molecular hubs in protein interaction networks. | 5.17e-06 | 111 | 136 | 6 | 22558309 | |
| Pubmed | CENPF POTEF MYO1B PRPF40A KIF20B DDX10 MFAP1 PAXBP1 MNAT1 GOLGB1 LRRFIP2 | 5.27e-06 | 506 | 136 | 11 | 30890647 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | SUPT20H MAP2 ZC3H13 HMGXB4 MYO1B LBR PRPF40A THOC5 ADD2 MFAP1 PAXBP1 KIN SUPT16H PRKDC CPSF2 RPL13 | 5.48e-06 | 1082 | 136 | 16 | 38697112 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | DOCK1 FNBP1 ABAT UACA MAP2 PCDH11Y ARHGEF38 NXN CREBBP JMJD1C DNAH1 ODF2L KIAA1217 SCAF11 TRMT13 EP300 CUX1 GOLGA4 GOLGB1 | 5.75e-06 | 1489 | 136 | 19 | 28611215 |
| Pubmed | 6.75e-06 | 67 | 136 | 5 | 30669930 | ||
| Pubmed | 6.84e-06 | 332 | 136 | 9 | 25693804 | ||
| Pubmed | 6.88e-06 | 10 | 136 | 3 | 20347598 | ||
| Pubmed | 8.08e-06 | 339 | 136 | 9 | 30415952 | ||
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | CENPF MYO1B URB2 LBR PRPF40A JMJD1C KIF20B DDX10 SCAF1 SQSTM1 UBTF SUPT16H SCAF11 PRKDC RPL13 | 8.15e-06 | 989 | 136 | 15 | 36424410 |
| Pubmed | Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS. | CDK11A NEB CREBBP SQSTM1 TAOK1 PRKDC PIP4K2C MNAT1 EP300 RPL13 | 8.33e-06 | 432 | 136 | 10 | 23455922 |
| Pubmed | SHANK1 ABAT MAP2 CPLX1 MRPS35 NDUFA10 YWHAH ASAP1 MRPS7 GSPT2 SQSTM1 KIAA1217 RABGAP1L HELZ LNPK RPL13 | 1.04e-05 | 1139 | 136 | 16 | 36417873 | |
| Pubmed | RAD18 SUPT20H ATR CHD8 CREBBP PRPF40A THOC5 MFAP1 BAZ1A UBTF SUPT16H PRKDC CPSF2 MNAT1 EP300 | 1.09e-05 | 1014 | 136 | 15 | 32416067 | |
| Pubmed | SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes. | 1.12e-05 | 353 | 136 | 9 | 27545878 | |
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | 1.13e-05 | 268 | 136 | 8 | 33024031 | |
| Pubmed | SHANK1 TPM3 MAP2 ITSN1 LRRC49 UPF3B PRPF40A YWHAH LETM1 CADM2 ADD2 LACTB ASAP1 AMOT KIAA1217 PIP4K2C RPL13 LRRFIP2 | 1.26e-05 | 1431 | 136 | 18 | 37142655 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 27881875 | ||
| Pubmed | Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasia. | 1.52e-05 | 2 | 136 | 2 | 34845315 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 19729597 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 39287984 | ||
| Pubmed | DNA structure-specific priming of ATR activation by DNA-PKcs. | 1.52e-05 | 2 | 136 | 2 | 23897887 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 20717166 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 25893291 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 11559821 | ||
| Pubmed | A primate-specific POTE-actin fusion protein plays a role in apoptosis. | 1.52e-05 | 2 | 136 | 2 | 19669888 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 32576962 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 19822209 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 24522976 | ||
| Pubmed | Timing and checkpoints in the regulation of mitotic progression. | 1.52e-05 | 2 | 136 | 2 | 15239953 | |
| Pubmed | CBP is required for environmental enrichment-induced neurogenesis and cognitive enhancement. | 1.52e-05 | 2 | 136 | 2 | 21847097 | |
| Pubmed | Intersectin-1 interacts with the golgin GCC88 to couple the actin network and Golgi architecture. | 1.52e-05 | 2 | 136 | 2 | 30540523 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 30670789 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 15548592 | ||
| Pubmed | Nuf2 and Hec1 are required for retention of the checkpoint proteins Mad1 and Mad2 to kinetochores. | 1.52e-05 | 2 | 136 | 2 | 14654001 | |
| Pubmed | p300 or CBP is required for insulin-stimulated glucose uptake in skeletal muscle and adipocytes. | 1.52e-05 | 2 | 136 | 2 | 34813504 | |
| Pubmed | The conserved KMN network constitutes the core microtubule-binding site of the kinetochore. | 1.52e-05 | 2 | 136 | 2 | 17129783 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 20301699 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 24639469 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 37816914 | ||
| Pubmed | Binding of p300/CBP co-activators by polyoma large T antigen. | 1.52e-05 | 2 | 136 | 2 | 11438528 | |
| Pubmed | Pathogenesis of Human Papillomaviruses Requires the ATR/p62 Autophagy-Related Pathway. | 1.52e-05 | 2 | 136 | 2 | 32788179 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 10918613 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 35502657 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 31898871 | ||
| Pubmed | Germline or inducible knockout of p300 or CBP in skeletal muscle does not alter insulin sensitivity. | 1.52e-05 | 2 | 136 | 2 | 30888860 | |
| Interaction | H3C1 interactions | RAD18 SUPT20H CEP290 HMGXB4 MRPS35 CHD8 LBR NEB CREBBP JMJD1C KIF20B ANKRD18B DNAH1 DDX10 MRPS7 GRPEL1 XIRP2 BAZ1A UBTF SUPT16H PRKDC EP300 CUX1 RPL13 | 6.54e-09 | 901 | 135 | 24 | int:H3C1 |
| Interaction | SRPK2 interactions | RAD18 ZC3H13 HMGXB4 MYO1B UPF3B URB2 LBR PRPF40A JMJD1C BAP1 SCAF1 MFAP1 VAC14 PAXBP1 BAZ1A SQSTM1 UBTF SUPT16H SCAF11 EP300 RPL13 | 1.28e-08 | 717 | 135 | 21 | int:SRPK2 |
| Interaction | HECTD1 interactions | CENPF UPF3B URB2 PRPF40A YWHAH KIF20B DDX10 FAM133B MRPS7 PAXBP1 KIN BAZ1A AMOT SQSTM1 UBTF SUPT16H SCAF11 PRKDC CPSF2 TXLNG EP300 RPL13 LRRFIP2 | 1.52e-07 | 984 | 135 | 23 | int:HECTD1 |
| Interaction | RAD18 interactions | TPM3 RAD18 ZC3H13 ITSN1 MYO1B FAM133B MRPS7 SCAF1 MFAP1 PAXBP1 SQSTM1 SUPT16H SCAF11 PRKDC CPSF2 | 4.39e-07 | 457 | 135 | 15 | int:RAD18 |
| Interaction | PHF21A interactions | TPM3 CENPF LRRC49 CHD8 NUF2 NDUFA10 JMJD1C KIF20B BAP1 AMOT SQSTM1 RABGAP1L GOLGB1 | 5.43e-07 | 343 | 135 | 13 | int:PHF21A |
| Interaction | DDX23 interactions | RAD18 ZC3H13 CDK11A PRPF40A THOC5 DDX10 SCAF1 MFAP1 PAXBP1 KIN UBTF SUPT16H SCAF11 PIP4K2C EP300 | 8.14e-07 | 480 | 135 | 15 | int:DDX23 |
| Interaction | CIT interactions | TPM3 CENPF ZC3H13 CDK11A MYO1B CHD8 NUF2 UPF3B CFAP43 PRPF40A THOC5 LACTB DDX10 SCAF1 MFAP1 PAXBP1 SQSTM1 UBTF SUPT16H SCAF11 DDX60L PRKDC CPSF2 CCDC180 CUX1 GOLGA4 RPL13 | 1.03e-06 | 1450 | 135 | 27 | int:CIT |
| Interaction | RCOR1 interactions | TPM3 FNBP1 CENPF ESRRB LRRC49 CHD8 NUF2 NDUFA10 JMJD1C KIF20B BAP1 AMOT SQSTM1 RABGAP1L CUX1 | 1.16e-06 | 494 | 135 | 15 | int:RCOR1 |
| Interaction | MYCN interactions | TPM3 MAP2 ZC3H13 HMGXB4 MRPS35 CDK11A MYO1B UPF3B LBR PRPF40A THOC5 PPL DDX10 FAM133B MRPS7 SCAF1 MFAP1 GRPEL1 PAXBP1 GSPT2 UBTF SCAF11 PRKDC CPSF2 EP300 RPL13 | 1.24e-06 | 1373 | 135 | 26 | int:MYCN |
| Interaction | CSNK2A1 interactions | KLHL6 RAD18 ZC3H13 CDK11A MYO1B UPF3B URB2 CREBBP PRPF40A THOC5 BAP1 MFAP1 BAZ1A SQSTM1 UBTF SUPT16H EIF5 PRKDC PIP4K2C EP300 RPL13 | 1.54e-06 | 956 | 135 | 21 | int:CSNK2A1 |
| Interaction | SMC5 interactions | PMS1 RAD18 ZC3H13 HMGXB4 CDK11A CHD8 LBR NDUFA10 PRPF40A JMJD1C KIF20B DDX10 MFAP1 PAXBP1 BAZ1A UBTF SUPT16H EIF5 SCAF11 PRKDC CUX1 | 3.12e-06 | 1000 | 135 | 21 | int:SMC5 |
| Interaction | CDK9 interactions | TPM3 PMS1 HSP90AB4P ATR ZC3H13 LBR CREBBP PRPF40A YWHAH MFAP1 NDC80 SQSTM1 SUPT16H PRKDC EP300 RPL13 LRRFIP2 | 3.41e-06 | 685 | 135 | 17 | int:CDK9 |
| Interaction | CHD4 interactions | FNBP1 RAD18 ATR ESRRB HMGXB4 CDK11A PRPF40A BAP1 DDX10 MFAP1 ODF2L PAXBP1 UBTF SUPT16H EIF5 SCAF11 PRKDC CPSF2 EP300 RPL13 | 4.39e-06 | 938 | 135 | 20 | int:CHD4 |
| Interaction | TERF2IP interactions | PMS1 RAD18 HMGXB4 CHD8 CREBBP PRPF40A KIF20B BAP1 DDX10 MFAP1 PAXBP1 UBTF SCAF11 MNAT1 CUX1 | 4.54e-06 | 552 | 135 | 15 | int:TERF2IP |
| Interaction | KDM1A interactions | TPM3 CENPF ESRRB LRRC49 CHD8 CAGE1 NDUFA10 JMJD1C KIF20B BAP1 AMOT SQSTM1 KIAA1217 RABGAP1L SUPT16H GCC1 CPSF2 EP300 CUX1 GOLGB1 | 4.61e-06 | 941 | 135 | 20 | int:KDM1A |
| Interaction | AP3B1 interactions | 4.81e-06 | 187 | 135 | 9 | int:AP3B1 | |
| Interaction | HMGB1 interactions | KIF21A MRPS35 CREBBP YWHAH BAP1 POTEE MRPS7 SQSTM1 SUPT16H PRKDC MNAT1 EP300 CUX1 RPL13 | 4.96e-06 | 486 | 135 | 14 | int:HMGB1 |
| Interaction | SYNC interactions | 5.77e-06 | 67 | 135 | 6 | int:SYNC | |
| Interaction | ANKRD20A4P interactions | 5.79e-06 | 6 | 135 | 3 | int:ANKRD20A4P | |
| Interaction | RPS6 interactions | RAD18 MRPS35 UPF3B URB2 LBR ANKRD18B LACTB BAP1 DDX10 MRPS7 MFAP1 GRPEL1 AFAP1L2 GSPT2 UBTF SUPT16H EIF5 GOLGB1 RPL13 | 5.93e-06 | 874 | 135 | 19 | int:RPS6 |
| Interaction | NDC80 interactions | UACA LRRC49 CEP290 CAGE1 NUF2 MFAP1 ODF2L NDC80 AMOT KIAA1217 TXLNG | 8.37e-06 | 312 | 135 | 11 | int:NDC80 |
| Interaction | OBSL1 interactions | TPM3 MAP2 CENPF MRPS35 URB2 LBR PRPF40A DNAH1 DDX10 POTEE SCAF1 MFAP1 SQSTM1 UBTF SUPT16H PRKDC CPSF2 GOLGB1 RPL13 | 9.28e-06 | 902 | 135 | 19 | int:OBSL1 |
| Interaction | ANKRD20A2P interactions | 1.01e-05 | 7 | 135 | 3 | int:ANKRD20A2P | |
| Interaction | H3-4 interactions | SUPT20H HSP90AB4P KIF21A CEP290 HMGXB4 CFAP43 LBR IQCD CREBBP DDX10 ANKRD18A EXOG EP300 | 1.02e-05 | 448 | 135 | 13 | int:H3-4 |
| Interaction | CTTN interactions | TPM3 RAD18 MYO1B PRPF40A ASAP1 BAP1 MFAP1 GSPT2 NDC80 AMOT SQSTM1 EP300 LRRFIP2 | 1.07e-05 | 450 | 135 | 13 | int:CTTN |
| Interaction | MED4 interactions | ZC3H13 ITSN1 ESRRB CEP290 CDK11A ODF2L NDC80 AMOT SQSTM1 SUPT16H GCC1 PIP4K2C TXLNG | 1.07e-05 | 450 | 135 | 13 | int:MED4 |
| Interaction | H3-3A interactions | PMS1 FNBP1 RAD18 HMGXB4 CHD8 CREBBP JMJD1C KIF20B DDX10 BAZ1A UBTF SUPT16H EIF5 SCAF11 PRKDC EP300 CUX1 | 1.10e-05 | 749 | 135 | 17 | int:H3-3A |
| Interaction | JUNB interactions | 1.47e-05 | 118 | 135 | 7 | int:JUNB | |
| Interaction | HDAC1 interactions | FNBP1 ATR CENPF ESRRB LRRC49 CHD8 NDUFA10 CREBBP JMJD1C KIF20B THOC5 BAP1 BAZ1A AMOT SQSTM1 UBTF CPSF2 EP300 CUX1 GOLGA4 GOLGB1 | 1.50e-05 | 1108 | 135 | 21 | int:HDAC1 |
| Interaction | SMARCA5 interactions | FNBP1 RAD18 ZC3H13 ESRRB HMGXB4 PRPF40A BAZ1A UBTF SUPT16H PRKDC CPSF2 RPL13 | 2.35e-05 | 415 | 135 | 12 | int:SMARCA5 |
| Interaction | BIRC3 interactions | TPM3 HSP90AB4P ATR CENPF MRPS35 MYO1B URB2 LBR NDUFA10 PRPF40A LETM1 DDX10 PAXBP1 BAZ1A AMOT SQSTM1 UBTF SUPT16H EIF5 PRKDC EP300 GOLGA4 RPL13 | 2.54e-05 | 1334 | 135 | 23 | int:BIRC3 |
| Interaction | MECOM interactions | MYO1B CAGE1 LBR NEB CREBBP GOLGA6L1 SQSTM1 RABGAP1L SUPT16H PRKDC CCDC180 | 3.00e-05 | 358 | 135 | 11 | int:MECOM |
| Interaction | LLGL2 interactions | 3.19e-05 | 133 | 135 | 7 | int:LLGL2 | |
| Interaction | HERC2 interactions | PMS1 CEP290 NUF2 PRPF40A THOC5 PPL LACTB PAXBP1 NDC80 TXLNG CUX1 NEK11 RPL13 | 3.42e-05 | 503 | 135 | 13 | int:HERC2 |
| Interaction | SRSF4 interactions | RAD18 KIF21A MRPS35 BAP1 DDX10 MRPS7 SCAF1 PAXBP1 SCAF11 EP300 | 3.52e-05 | 300 | 135 | 10 | int:SRSF4 |
| Interaction | PPP1CC interactions | TPM3 SPAG1 RAD18 UACA ZC3H13 MYO1B NUF2 LBR CREBBP PRPF40A NDC80 KIAA1217 SUPT16H EP300 RPL13 LRRFIP2 | 3.55e-05 | 738 | 135 | 16 | int:PPP1CC |
| Interaction | ANKRD20A1 interactions | 4.66e-05 | 11 | 135 | 3 | int:ANKRD20A1 | |
| Interaction | CHD3 interactions | ZC3H13 HMGXB4 MYO1B CREBBP PRPF40A DDX10 PAXBP1 BAZ1A UBTF SUPT16H SCAF11 PRKDC CPSF2 EP300 CUX1 RPL13 | 4.80e-05 | 757 | 135 | 16 | int:CHD3 |
| Interaction | MAX interactions | 5.00e-05 | 251 | 135 | 9 | int:MAX | |
| Interaction | EXOC1 interactions | 5.08e-05 | 143 | 135 | 7 | int:EXOC1 | |
| Interaction | RPL31 interactions | RAD18 ZC3H13 CDK11A UPF3B URB2 BAP1 DDX10 SCAF1 MFAP1 KIN UBTF SUPT16H EIF5 TXLNG RPL13 | 5.20e-05 | 680 | 135 | 15 | int:RPL31 |
| Interaction | UFL1 interactions | TPM3 CDK11A MYO1B UPF3B LBR PRPF40A MRPS7 MFAP1 PAXBP1 GSPT2 UBTF SUPT16H DNAJC1 PRKDC LNPK CFAP57 CPSF2 EP300 RPL13 | 5.82e-05 | 1031 | 135 | 19 | int:UFL1 |
| Interaction | CDC5L interactions | PMS1 FNBP1 RAD18 ATR KIF21A CHD8 NUF2 PRPF40A BAP1 PAXBP1 NDC80 UBTF PRKDC CPSF2 EP300 GOLGB1 RPL13 | 5.87e-05 | 855 | 135 | 17 | int:CDC5L |
| Interaction | H2BC21 interactions | TPM3 CENPF HMGXB4 CHD8 NEB CREBBP JMJD1C BAZ1A SUPT16H SCAF11 DDX60L PRKDC MNAT1 EP300 LRRFIP2 | 6.76e-05 | 696 | 135 | 15 | int:H2BC21 |
| Interaction | RCHY1 interactions | RAD18 CHD8 PRPF40A MRPS7 GRPEL1 GSPT2 AMOT UBTF SUPT16H RPL13 | 6.88e-05 | 325 | 135 | 10 | int:RCHY1 |
| Interaction | CCDC77 interactions | 6.95e-05 | 64 | 135 | 5 | int:CCDC77 | |
| Interaction | CDK2 interactions | KLHL6 TPM3 ATR MYO1B CREBBP YWHAH FAM133B MFAP1 SQSTM1 UBTF SUPT16H PRKDC MNAT1 EP300 RPL13 LRRFIP2 | 7.15e-05 | 783 | 135 | 16 | int:CDK2 |
| Interaction | IFI27L1 interactions | 7.49e-05 | 65 | 135 | 5 | int:IFI27L1 | |
| Interaction | DYRK1A interactions | RAD18 SUPT20H CENPF CREBBP YWHAH PPL MFAP1 SQSTM1 KIAA1217 EP300 GOLGB1 RPL13 LRRFIP2 | 8.80e-05 | 552 | 135 | 13 | int:DYRK1A |
| Interaction | BTF3 interactions | TPM3 UACA ITSN1 MYO1B YWHAH BAP1 SQSTM1 UBTF KIAA1217 SUPT16H PRKDC LNPK TXLNG CUX1 RPL13 LRRFIP2 | 9.06e-05 | 799 | 135 | 16 | int:BTF3 |
| Interaction | KIAA0753 interactions | 9.16e-05 | 157 | 135 | 7 | int:KIAA0753 | |
| Interaction | CEP135 interactions | 9.25e-05 | 272 | 135 | 9 | int:CEP135 | |
| Interaction | PPIA interactions | CENPF ITSN1 HMGXB4 CPLX1 CHD8 LBR ASAP1 BAP1 BAZ1A SQSTM1 SUPT16H LNPK PIP4K2C CPSF2 MNAT1 CUX1 GOLGA4 | 9.33e-05 | 888 | 135 | 17 | int:PPIA |
| Interaction | NANOG interactions | CENPF ESRRB MRPS35 JMJD1C KIF20B THOC5 SQSTM1 UBTF KIAA1217 SUPT16H SCAF11 EP300 | 9.70e-05 | 481 | 135 | 12 | int:NANOG |
| Interaction | SNRPA interactions | RAD18 CPLX1 PRPF40A THOC5 MFAP1 PAXBP1 KIN SUPT16H SCAF11 PRKDC CPSF2 EP300 | 9.89e-05 | 482 | 135 | 12 | int:SNRPA |
| Interaction | TERF2 interactions | CENPF ZC3H13 CHD8 LBR PRPF40A POTEE AFAP1L2 PAXBP1 EP300 RPL13 | 1.00e-04 | 340 | 135 | 10 | int:TERF2 |
| Interaction | PRPF38A interactions | 1.07e-04 | 161 | 135 | 7 | int:PRPF38A | |
| Interaction | TMOD1 interactions | 1.07e-04 | 161 | 135 | 7 | int:TMOD1 | |
| Interaction | SNIP1 interactions | RAD18 ATR CREBBP PRPF40A DDX10 SCAF1 MFAP1 SUPT16H PRKDC CPSF2 EP300 | 1.17e-04 | 417 | 135 | 11 | int:SNIP1 |
| Interaction | CLK3 interactions | 1.20e-04 | 220 | 135 | 8 | int:CLK3 | |
| Interaction | BRD3 interactions | TPM3 RAD18 SUPT20H HMGXB4 CHD8 PRPF40A SCAF1 MFAP1 BAZ1A UBTF SUPT16H PIP4K2C | 1.25e-04 | 494 | 135 | 12 | int:BRD3 |
| Interaction | KIAA1217 interactions | 1.25e-04 | 115 | 135 | 6 | int:KIAA1217 | |
| Interaction | KLF2 interactions | 1.26e-04 | 15 | 135 | 3 | int:KLF2 | |
| Interaction | H3C3 interactions | PMS1 RAD18 HMGXB4 CHD8 JMJD1C KIF20B BAP1 BAZ1A UBTF SUPT16H SCAF11 CUX1 | 1.27e-04 | 495 | 135 | 12 | int:H3C3 |
| Interaction | RNF123 interactions | PMS1 CENPF ZC3H13 KIF21A ITSN1 CEP290 ANKRD20A3P NDUFA10 POTEE SCAF1 AFAP1L2 AMOT ANKRD18A PRKDC CFAP57 LRRFIP2 | 1.29e-04 | 824 | 135 | 16 | int:RNF123 |
| Interaction | H2BC8 interactions | RAD18 HMGXB4 CHD8 UPF3B KIF20B DDX10 POTEE BAZ1A UBTF SUPT16H SCAF11 MNAT1 CUX1 | 1.34e-04 | 576 | 135 | 13 | int:H2BC8 |
| Interaction | SMARCC2 interactions | FNBP1 ITSN1 ESRRB CREBBP PRPF40A BAZ1A SUPT16H CPSF2 TXLNG EP300 | 1.36e-04 | 353 | 135 | 10 | int:SMARCC2 |
| Interaction | KANK1 interactions | 1.46e-04 | 40 | 135 | 4 | int:KANK1 | |
| Interaction | NR2C2 interactions | TPM3 ZC3H13 MRPS35 CHD8 LBR NDUFA10 PRPF40A ADD2 BAP1 DDX10 FAM133B MRPS7 SCAF1 MFAP1 PAXBP1 SUPT16H HELZ TAOK1 PRKDC PIP4K2C CPSF2 RPL13 | 1.57e-04 | 1403 | 135 | 22 | int:NR2C2 |
| Interaction | PCM1 interactions | CETN3 LRRC49 CEP290 NUF2 CCDC92 BIN3 YWHAH ODF2L NDC80 KIAA1217 TXLNG | 1.66e-04 | 434 | 135 | 11 | int:PCM1 |
| Interaction | MTA2 interactions | FNBP1 RAD18 ATR ESRRB HMGXB4 CDK11A BAP1 BAZ1A PRKDC CPSF2 EP300 | 1.70e-04 | 435 | 135 | 11 | int:MTA2 |
| Interaction | PARP1 interactions | RAD18 CDK11A URB2 LBR NXN CREBBP PRPF40A BAP1 DDX10 SCAF1 MFAP1 KIN BAZ1A SQSTM1 UBTF SUPT16H SCAF11 PRKDC CPSF2 EP300 CUX1 | 1.78e-04 | 1316 | 135 | 21 | int:PARP1 |
| Interaction | SP1 interactions | 1.78e-04 | 365 | 135 | 10 | int:SP1 | |
| Interaction | FXR1 interactions | SHANK1 CENPF KIF21A ITSN1 GBP2 UPF3B CCDC92 YWHAH BAP1 MFAP1 HELZ EXOG EP300 GOLGB1 | 1.89e-04 | 679 | 135 | 14 | int:FXR1 |
| Interaction | HSF2 interactions | 1.90e-04 | 79 | 135 | 5 | int:HSF2 | |
| Interaction | DDA1 interactions | 1.90e-04 | 368 | 135 | 10 | int:DDA1 | |
| Interaction | KRT8 interactions | UACA LRRC49 KIF16B NUF2 YWHAH PPL BAP1 NDC80 SQSTM1 HELZ CUX1 | 1.91e-04 | 441 | 135 | 11 | int:KRT8 |
| Interaction | SYNJ2 interactions | 1.94e-04 | 43 | 135 | 4 | int:SYNJ2 | |
| Interaction | HDLBP interactions | TPM3 UACA UPF3B LBR NDUFA10 PRPF40A THOC5 LACTB BAP1 PAXBP1 SQSTM1 SUPT16H TAOK1 PRKDC CPSF2 LRRFIP2 | 1.97e-04 | 855 | 135 | 16 | int:HDLBP |
| Interaction | ZNF330 interactions | RAD18 HMGXB4 CDK11A URB2 DDX10 MFAP1 KIN BAZ1A UBTF SUPT16H CUX1 | 2.11e-04 | 446 | 135 | 11 | int:ZNF330 |
| Interaction | SYCE1 interactions | 2.15e-04 | 127 | 135 | 6 | int:SYCE1 | |
| Interaction | TP53BP2 interactions | 2.24e-04 | 241 | 135 | 8 | int:TP53BP2 | |
| Interaction | YEATS4 interactions | 2.29e-04 | 182 | 135 | 7 | int:YEATS4 | |
| Interaction | KIF20A interactions | TPM3 UACA MYO1B CHD8 PRPF40A PPL LACTB POTEE MFAP1 PAXBP1 SQSTM1 RABGAP1L SUPT16H HELZ ANKRD18A PRKDC CPSF2 RPL13 | 2.33e-04 | 1052 | 135 | 18 | int:KIF20A |
| Interaction | BZW1 interactions | 2.36e-04 | 183 | 135 | 7 | int:BZW1 | |
| Interaction | YWHAG interactions | TPM3 UACA MAP2 POTEF ZC3H13 LBR PRPF40A YWHAH BAP1 AFAP1L1 MFAP1 BAZ1A AMOT SQSTM1 RABGAP1L EIF5 HELZ TAOK1 SCAF11 PRKDC | 2.43e-04 | 1248 | 135 | 20 | int:YWHAG |
| Interaction | TOP1 interactions | PMS1 RAD18 BIN3 PRPF40A THOC5 BAP1 SCAF1 MFAP1 NDC80 BAZ1A SUPT16H SCAF11 PRKDC CPSF2 | 2.44e-04 | 696 | 135 | 14 | int:TOP1 |
| Interaction | CALCOCO1 interactions | 2.53e-04 | 84 | 135 | 5 | int:CALCOCO1 | |
| Interaction | NEUROG1 interactions | 2.63e-04 | 19 | 135 | 3 | int:NEUROG1 | |
| Interaction | BRCC3 interactions | 2.65e-04 | 132 | 135 | 6 | int:BRCC3 | |
| Interaction | NKAP interactions | 2.65e-04 | 132 | 135 | 6 | int:NKAP | |
| Interaction | MEX3A interactions | KLHL6 CENPF ITSN1 CHD8 URB2 CREBBP LETM1 SUPT16H PRKDC EP300 | 2.67e-04 | 384 | 135 | 10 | int:MEX3A |
| Interaction | DHX40 interactions | 2.79e-04 | 249 | 135 | 8 | int:DHX40 | |
| Interaction | HSPB1 interactions | TPM3 CETN3 LBR CREBBP PRPF40A YWHAH LETM1 THOC5 MFAP1 GRPEL1 SQSTM1 KIAA1217 EIF5 PRKDC | 2.90e-04 | 708 | 135 | 14 | int:HSPB1 |
| Interaction | CSNK2B interactions | RAD18 ITSN1 CDK11A GBP2 CHD8 CREBBP BAP1 DDX10 SUPT16H EIF5 PIP4K2C EP300 RPL13 | 2.97e-04 | 625 | 135 | 13 | int:CSNK2B |
| Interaction | APEX1 interactions | RAD18 UACA CENPF ITSN1 CEP290 CDK11A KIF20B BAP1 FAN1 DDX10 MFAP1 VAC14 ODF2L BAZ1A UBTF EIF5 SCAF11 PRKDC EP300 CUX1 | 3.09e-04 | 1271 | 135 | 20 | int:APEX1 |
| Interaction | IFI16 interactions | UACA UPF3B URB2 PRPF40A DDX10 SQSTM1 UBTF RABGAP1L SUPT16H HELZ DDX60L EP300 RPL13 LRRFIP2 | 3.16e-04 | 714 | 135 | 14 | int:IFI16 |
| Interaction | HECW2 interactions | 3.26e-04 | 322 | 135 | 9 | int:HECW2 | |
| Interaction | RB1 interactions | CENPF CREBBP NDC80 UBTF RABGAP1L HELZ CCDC180 MNAT1 EP300 CUX1 | 3.28e-04 | 394 | 135 | 10 | int:RB1 |
| Interaction | STMN1 interactions | 3.48e-04 | 195 | 135 | 7 | int:STMN1 | |
| Cytoband | 15q22.1 | 1.81e-04 | 7 | 136 | 2 | 15q22.1 | |
| GeneFamily | Ankyrin repeat domain containing | SHANK1 UACA POTEF ANKRD30B ANKRD20A2P ANKRD20A3P ANKRD18B ASAP1 POTEE ANKRD20A4P ANKRD18A ANKRD20A1 | 4.29e-10 | 242 | 77 | 12 | 403 |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 5.79e-05 | 18 | 77 | 3 | 91 | |
| GeneFamily | Phosphoinositide phosphatases | 3.37e-04 | 32 | 77 | 3 | 1079 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 9.88e-04 | 46 | 77 | 3 | 622 | |
| GeneFamily | Ankyrin repeat domain containing|POTE ankyrin domain containing | 1.35e-03 | 13 | 77 | 2 | 685 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 2.34e-03 | 17 | 77 | 2 | 486 | |
| GeneFamily | Mitochondrial ribosomal proteins | 4.66e-03 | 79 | 77 | 3 | 646 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | FNBP1 RAD18 ATR CETN3 CEP290 KIF16B NUF2 KIF20B DDX10 MFAP1 NDC80 BAZ1A RABGAP1L SCAF11 DNAJC1 MNAT1 GOLGA4 GOLGB1 | 8.18e-09 | 656 | 135 | 18 | M18979 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | DOCK1 PMS1 SUPT20H ATR CENPF ITSN1 HMGXB4 MYO1B CREBBP KIF20B DDX10 KIN NDC80 BAZ1A RABGAP1L HELZ MNAT1 CUX1 GOLGA4 | 8.85e-08 | 856 | 135 | 19 | M4500 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | PMS1 ATR CENPF ITSN1 HMGXB4 MYO1B CREBBP KIF20B NDC80 BAZ1A HELZ MNAT1 CUX1 GOLGA4 | 1.40e-07 | 466 | 135 | 14 | M13522 |
| Coexpression | DESCARTES_ORGANOGENESIS_PRIMITIVE_ERYTHROID_LINEAGE | RAD18 CENPF NUF2 ANKRD20A3P ANKRD20A8P LBR ANKRD18B MFAP1 ANKRD20A4P NDC80 ANKRD18A PIP4K2C ANKRD20A1 RPL13 | 3.04e-07 | 497 | 135 | 14 | MM3640 |
| Coexpression | IWANAGA_CARCINOGENESIS_BY_KRAS_UP | ANKRD20A3P ANKRD20A8P CREBBP CREB3L1 ANKRD18B ANKRD20A4P ANKRD18A ANKRD20A1 | 7.18e-06 | 192 | 135 | 8 | MM752 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 2.65e-05 | 300 | 135 | 9 | M8702 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | TPM3 CENPF KIF21A CEP290 PRPF40A KIF20B FAM133B NDC80 BAZ1A SUPT16H EIF5 TAOK1 SCAF11 PRKDC LNPK TXLNG | 2.57e-07 | 532 | 134 | 16 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | CENPF CEP290 UPF3B KIF20B LETM1 ODF2L BAZ1A SUPT16H PRKDC CUX1 GOLGA4 LRRFIP2 | 6.75e-07 | 311 | 134 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | TPM3 PMS1 RAD18 ATR CENPF ZC3H13 KIF21A LRRC49 CEP290 UPF3B PRPF40A KIF20B DDX10 ODF2L KIN NDC80 BAZ1A SUPT16H EIF5 SCAF11 DNAJC1 LNPK CPSF2 CUX1 | 1.04e-06 | 1257 | 134 | 24 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | TPM3 PMS1 RAD18 ATR MAP2 CENPF ZC3H13 KIF21A LRRC49 CEP290 UPF3B PRPF40A KIF20B ADD2 DDX10 ODF2L KIN NDC80 BAZ1A SUPT16H EIF5 SCAF11 DNAJC1 LNPK CPSF2 CUX1 | 1.26e-06 | 1459 | 134 | 26 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000 | DOCK1 RAD18 CENPF HMGXB4 PRPF40A KIF20B BAZ1A EIF5 TRMT13 CUX1 GOLGA4 | 1.05e-05 | 339 | 134 | 11 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | CENPF KIF21A CEP290 UPF3B NDUFA10 NXN KIF20B LETM1 MFAP1 ODF2L BAZ1A SUPT16H DNAJC1 PRKDC CUX1 GOLGA4 LRRFIP2 | 1.95e-05 | 831 | 134 | 17 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | CENPF KIF21A CEP290 CHD8 UPF3B GSPT2 BAZ1A SUPT16H TAOK1 SCAF11 | 2.01e-05 | 298 | 134 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 3.05e-05 | 192 | 134 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | dev gonad_e11.5_M_PrimGermCell_Oct_top-relative-expression-ranked_1000 | PMS1 RAD18 ATR CENPF ESRRB URB2 LBR KIF20B DDX10 VAC14 ZNF566 HELZ PRKDC TXLNG RPL13 | 1.25e-04 | 781 | 134 | 15 | gudmap_dev gonad_e11.5_M_PrimGermCell_Oct_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | MAP2 CENPF KIF21A CEP290 UPF3B KIF20B LETM1 DDX10 VAC14 ODF2L BAZ1A SUPT16H DNAJC1 PRKDC CUX1 GOLGA4 LRRFIP2 | 1.66e-04 | 989 | 134 | 17 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | DOCK1 TPM3 UACA CENPF CEP290 PRPF40A KIF20B BAZ1A SUPT16H SCAF11 PRKDC | 1.95e-04 | 469 | 134 | 11 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.16e-04 | 323 | 134 | 9 | gudmap_developingGonad_e11.5_ovary + mesonephros_k2_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 2.21e-04 | 192 | 134 | 7 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | CENPF ZC3H13 CEP290 PRPF40A KIF20B ODF2L BAZ1A SCAF11 DNAJC1 GOLGA4 GOLGB1 | 2.73e-11 | 198 | 136 | 11 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | SPAG1 UACA ZC3H13 KIF21A CEP290 PRPF40A ODF2L BAZ1A ANKRD18A GOLGA4 GOLGB1 | 2.89e-11 | 199 | 136 | 11 | 61b1ed2db71b96157b92b7535d1955a4033098da |
| ToppCell | COPD-Myeloid-cDC1|Myeloid / Disease state, Lineage and Cell class | FNBP1 KIF16B ANKRD20A2P ANKRD20A3P ANKRD20A8P VAC14 ANKRD20A4P TACSTD2 ANKRD20A1 | 7.80e-09 | 191 | 136 | 9 | 3480e6d27dd4291765bbbb2acdb6a2e4f02c8085 |
| ToppCell | COPD-Myeloid-cDC1|COPD / Disease state, Lineage and Cell class | KLHL6 KIF16B ANKRD20A2P ANKRD20A3P ANKRD20A8P VAC14 ANKRD20A4P TACSTD2 ANKRD20A1 | 8.16e-09 | 192 | 136 | 9 | bd3d00b094d92463b06023361a71240851a542b8 |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate|6m / Sample Type, Dataset, Time_group, and Cell type. | 1.16e-08 | 200 | 136 | 9 | 7c261e39ac30b318511373ab7302aa53b8b81b9c | |
| ToppCell | COPD-Myeloid-cDC1|World / Disease state, Lineage and Cell class | KIF16B ANKRD20A2P ANKRD20A3P ANKRD20A8P VAC14 ANKRD20A4P TACSTD2 ANKRD20A1 | 1.01e-07 | 184 | 136 | 8 | 42d7ce104cd7bcb83fbbbd0e7d3267ad07edfa94 |
| ToppCell | IPF-Myeloid-cDC1|World / Disease state, Lineage and Cell class | KIF16B ANKRD20A2P ANKRD20A3P ANKRD20A8P VAC14 ANKRD20A4P TACSTD2 ANKRD20A1 | 1.10e-07 | 186 | 136 | 8 | 962c2dada19185628ead77c32fcb07fa95114247 |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-07 | 187 | 136 | 8 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | nucseq-Immune-Immune_Myeloid-Myeloid_Dendritic-cDC1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.19e-07 | 188 | 136 | 8 | d5ce3ffe783c322b4765b790e861727e46bc34b3 | |
| ToppCell | IPF-Myeloid-cDC1|IPF / Disease state, Lineage and Cell class | KIF16B ANKRD20A2P ANKRD20A3P ANKRD20A8P VAC14 ANKRD20A4P TACSTD2 ANKRD20A1 | 1.19e-07 | 188 | 136 | 8 | 2331a2bae1383820d598e93aa86c75b101069bac |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.52e-07 | 194 | 136 | 8 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 1.71e-07 | 197 | 136 | 8 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.78e-07 | 198 | 136 | 8 | 1847ce8c344c8a3e50f3cbbf758a38aba69f85b0 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 1.85e-07 | 199 | 136 | 8 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Ciliated|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.92e-07 | 200 | 136 | 8 | 6a2ccc71a0cbe04a542c379b28b5006de53981c3 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.92e-07 | 200 | 136 | 8 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.70e-07 | 168 | 136 | 7 | 9a8709d34865cfa668d8f3335dc34fc86fc32482 | |
| ToppCell | 367C-Myeloid-Dendritic-cDC1|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.48e-06 | 182 | 136 | 7 | 6f5228ac47f9ab46d165740cf2655b5ba217acbe | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 1.54e-06 | 183 | 136 | 7 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-4|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 1.60e-06 | 184 | 136 | 7 | d9659d1e4465fec68f48a22edef443f354f6c7cf | |
| ToppCell | Control-Myeloid-cDC1|Control / Disease state, Lineage and Cell class | KLHL6 ANKRD20A2P ANKRD20A3P ANKRD20A8P ANKRD20A4P TACSTD2 ANKRD20A1 | 1.72e-06 | 186 | 136 | 7 | b05c394aa3573ba855abc3066739ca193883b0c3 |
| ToppCell | IPF-Myeloid-cDC1|Myeloid / Disease state, Lineage and Cell class | KIF16B ANKRD20A2P ANKRD20A3P ANKRD20A8P ANKRD20A4P TACSTD2 ANKRD20A1 | 1.84e-06 | 188 | 136 | 7 | 47bb6caf84f70a1cda7d09803afdfd5182772e66 |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neuron_precursor-cycling_neuroblast|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.91e-06 | 189 | 136 | 7 | 815afad947ed77a8b03724bf78014799fed34f54 | |
| ToppCell | ASK440-Epithelial-Ciliated|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.27e-06 | 194 | 136 | 7 | c84a7fa94fb06e08aae04db56c8c313b0afde1d7 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3_mon|organoid_Paulsen_bioRxiv / Sample Type, Dataset, Time_group, and Cell type. | 2.27e-06 | 194 | 136 | 7 | 4903a0d6e36599bcb83b179462e5b949df9eb685 | |
| ToppCell | Control-Neu_4|Control / 5 Neutrophil clusters in COVID-19 patients | 2.43e-06 | 196 | 136 | 7 | b8b7b54ca17a08fa775507bb22b1c7248ada8f40 | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 2.69e-06 | 199 | 136 | 7 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 2.69e-06 | 199 | 136 | 7 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_E|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 8.87e-06 | 157 | 136 | 6 | 432b8719a8afd289cf48068e12c26a349d753fcc | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.14e-05 | 164 | 136 | 6 | e4d4c59aebe5cacd4ecdb907facd044dc82a831d | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_vein-D175|Adult / Lineage, Cell type, age group and donor | 1.35e-05 | 169 | 136 | 6 | e1f0298236e4a1c59077c14f0dd29a78fac12648 | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.39e-05 | 170 | 136 | 6 | 2d5e56eee0c3ce75a9641cc14dee0e0807141c32 | |
| ToppCell | (07)_Ionocytes-(2)_GFP_FOXI1|(07)_Ionocytes / shred by cell type by condition | 1.49e-05 | 172 | 136 | 6 | 5776b638b845d054f6e884e7df0412477f48517d | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Myeloid-cDC1|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.54e-05 | 173 | 136 | 6 | d13ae4046a25ee0fb492ddedf44583a879a432e9 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.64e-05 | 175 | 136 | 6 | 15c69dd5635c9251c535f1e22467712e9667ae92 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.64e-05 | 175 | 136 | 6 | 9de288c338cee67be0e9b836c87799bbc1db1c38 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-05 | 176 | 136 | 6 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-CD141+_DCs|normal_Pleural_Fluid / Location, Cell class and cell subclass | 1.70e-05 | 176 | 136 | 6 | 195393b38f1335f2cb96125616d75c164a6026c2 | |
| ToppCell | ASK454-Epithelial-Ciliated|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.87e-05 | 179 | 136 | 6 | f21919ef9d3d984e2925ef3d24f89e20fe265dcd | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.93e-05 | 180 | 136 | 6 | 92fb01b91261b3103454924cde56add337b41844 | |
| ToppCell | Control-Myeloid-cDC1|Myeloid / Disease state, Lineage and Cell class | ANKRD20A2P ANKRD20A3P ANKRD20A8P ANKRD20A4P TACSTD2 ANKRD20A1 | 2.18e-05 | 184 | 136 | 6 | c6affa0b12510363258f65e46bf2d47bf4a8e75f |
| ToppCell | Control-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 2.18e-05 | 184 | 136 | 6 | ce7f044956613118ee2e9fb6af2455c3166cb414 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-conventional_dendritic_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.25e-05 | 185 | 136 | 6 | 209c7d769dd01c349f0a6d147ac9d6225a85160f | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-conventional_dendritic_cell-DC1_(conventional_dendritic_cell)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.25e-05 | 185 | 136 | 6 | 1f37191eeddaf95e1ad1a206fee86525a2e94e51 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-conventional_dendritic_cell-DC1_(conventional_dendritic_cell)-DC1_L.1.2.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.25e-05 | 185 | 136 | 6 | 70d3f804b43a8843c5af53aefe677fdfc8bb61ff | |
| ToppCell | Control-Myeloid-cDC1|World / Disease state, Lineage and Cell class | 2.32e-05 | 186 | 136 | 6 | 3de803dee3ef10eb85a2b47d3f93385214e5b0ff | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 2.32e-05 | 186 | 136 | 6 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | 367C-Myeloid-Dendritic-cDC1|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.39e-05 | 187 | 136 | 6 | 3748203b62abf51b74dfcfc4f18b3ba831b63a96 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-Ciliated_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-05 | 187 | 136 | 6 | 04dba2ed09ee4180830bdf0191921696697ea234 | |
| ToppCell | PND28-Epithelial-Epithelial_Airway|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.39e-05 | 187 | 136 | 6 | f777dd5eb5ccd554ebe1ed60a738b5dd45e18bb9 | |
| ToppCell | PND03|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.39e-05 | 187 | 136 | 6 | b3fcb36d853adfdea7172c5591de06f027e50af3 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-05 | 187 | 136 | 6 | 805dafe22f835ece4dd091d8030d0a63b52a48dd | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.54e-05 | 189 | 136 | 6 | 02c6128a9ab5818e0881dcadafdad5f08b9a67cf | |
| ToppCell | PND28-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.54e-05 | 189 | 136 | 6 | fa1ff8b7fa53f3148d9117d6e598097f03af5eb2 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.54e-05 | 189 | 136 | 6 | 164ea92ff6a1aa2ead1c9b8f64f99a9d65437232 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.54e-05 | 189 | 136 | 6 | 407d8a59969d83f014600aae1a55092283a13970 | |
| ToppCell | PND28-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.54e-05 | 189 | 136 | 6 | 565063f9e3dd79164321f8a394bd12c176baf202 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.54e-05 | 189 | 136 | 6 | a85099bd598a27ee64ee0664d051d89fa8d62fc9 | |
| ToppCell | PND28-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.54e-05 | 189 | 136 | 6 | 497be236848ebf5ad75d1f0c71e6261f5d3521da | |
| ToppCell | facs-Lung-3m-Epithelial-airway_epithelial-lung_ciliated_cell-ciliated_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.69e-05 | 191 | 136 | 6 | 649fcb62ad15de2f83e61591e43923a717664ae7 | |
| ToppCell | facs-Lung-3m-Epithelial-airway_epithelial-lung_ciliated_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.69e-05 | 191 | 136 | 6 | 9621e22e14ea069f22713947c9faa2d882abe5fe | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-05 | 191 | 136 | 6 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | E17.5-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.69e-05 | 191 | 136 | 6 | efe0cb0b6602621f5eda72a723b83b38bf15607f | |
| ToppCell | ASK428-Epithelial-Ciliated|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.69e-05 | 191 | 136 | 6 | 0c4b926a28bc94f3cf4d68a911c0a189f6ff505e | |
| ToppCell | (3)_MNP-(3)_DC_1|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.69e-05 | 191 | 136 | 6 | cf0ea54670ed478c3302ccfbee9f6b6706e49fcd | |
| ToppCell | E17.5-Endothelial-proliferative_endothelial_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.69e-05 | 191 | 136 | 6 | 00676c598f6dae0ff9158d064248f1265432f3e1 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-05 | 191 | 136 | 6 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | facs-Lung-3m-Epithelial-airway_epithelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.69e-05 | 191 | 136 | 6 | 6a8fc9dc1a4c7115862e8f20204fa2f95e50e22f | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-05 | 191 | 136 | 6 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | droplet-Skin-nan-21m-Epithelial-stem_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-05 | 192 | 136 | 6 | 96f23d6e8604d1cb24910d3118d8171b57c93e14 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.77e-05 | 192 | 136 | 6 | 1b6cac8156e608061e1405e36e18d185b6fa8f6f | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.85e-05 | 193 | 136 | 6 | e1b76102f812c433195d1e8811fdd3293a7bc22e | |
| ToppCell | P07-Endothelial-proliferative_endothelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.85e-05 | 193 | 136 | 6 | 1e95ef29357969ee385b4717c0b5a497390ac260 | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial-proliferating|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-05 | 193 | 136 | 6 | f20b90e3f3f5c9a1ae51c5ebe6d3adb954a142f2 | |
| ToppCell | wk_20-22-Hematologic-Myeloid-DC1|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.85e-05 | 193 | 136 | 6 | a260d943e9db966e4ce7d642313fd11354c2d2ba | |
| ToppCell | ASK440-Epithelial-Ciliated|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.85e-05 | 193 | 136 | 6 | a0baa8be6f590b2031fede22be588715ae458e93 | |
| ToppCell | P07-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.85e-05 | 193 | 136 | 6 | 0f21fb8b35f89f4c1c8109d1a4d3d08a452f9edd | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_Prolif-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.94e-05 | 194 | 136 | 6 | 7a66bd7d4fc9c6db861cedd2487f241e406869d1 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-B_cells-Cycling_plasma_cell|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.94e-05 | 194 | 136 | 6 | 06b8dc2e46f833707d5b68b324b4ff6c4d0dccf9 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated-Deuterosomal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.02e-05 | 195 | 136 | 6 | e525b69145059b66417589601f7109af63730f3a | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial-Ciliated|Control_saline / Treatment groups by lineage, cell group, cell type | 3.02e-05 | 195 | 136 | 6 | 60067b5359174f0d1a8b5748bfc0690762e9e740 | |
| ToppCell | 367C-Myeloid-Dendritic-cDC1|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 3.02e-05 | 195 | 136 | 6 | fca958f73de450ef813444d3dc590353f1c55326 | |
| ToppCell | PSB-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.20e-05 | 197 | 136 | 6 | 6865f4831eb23794fb88a8649d48d497bbae3f44 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.20e-05 | 197 | 136 | 6 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | Bronchial_Brush-Epithelial|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.20e-05 | 197 | 136 | 6 | 272c7f4e582ef57564450540242b0db766b78328 | |
| ToppCell | control-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.20e-05 | 197 | 136 | 6 | e453d085182364ca347cbcc9dc995c62c3353016 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 3.20e-05 | 197 | 136 | 6 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | control-Epithelial-Ciliated|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.20e-05 | 197 | 136 | 6 | d4e963c1f82996371bf3d63578ee9fce8e00c5a8 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Proliferating-cycling_dorsal_progenitors|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 3.29e-05 | 198 | 136 | 6 | 5f0964c3aa7e1dc52cbb46e754078920b65bcb88 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Proliferating|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 3.29e-05 | 198 | 136 | 6 | 629d674a9c9108c1acb3f7af57bbdbf34bb0528e | |
| ToppCell | NS-critical-d_07-13|critical / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.29e-05 | 198 | 136 | 6 | a6e11c87b31beffb6af190c64b4ef3ee1d9dab8d | |
| ToppCell | (11)_FOXN4+|World / shred by cell type by condition | 3.29e-05 | 198 | 136 | 6 | 516b1acdf997dd8debc3dca066519366e507b414 | |
| ToppCell | critical-Epithelial|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.39e-05 | 199 | 136 | 6 | bbb44e2a52f102a6d891ead6c06d6c07221abd33 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-cDC1|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.39e-05 | 199 | 136 | 6 | c6da5c517dbcfa621fa6dda9e0c1985ba2f3bbdb | |
| ToppCell | ASK452-Epithelial|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.39e-05 | 199 | 136 | 6 | e8778d4d2bc7e15b4c7989a93e5808a76738df46 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-cDC1-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.39e-05 | 199 | 136 | 6 | b9613e88c4b752529d6ae20857744418207b0830 | |
| ToppCell | NS-critical-d_07-13-Epithelial|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.39e-05 | 199 | 136 | 6 | b88a81cd2a89f4d27100c96ae4324dcee68daf83 | |
| ToppCell | Megakaryocytic-erythropoietic-Erythro-cells-Polychromatic_Erythroblast|Megakaryocytic-erythropoietic / Lineage, cell class and subclass | 3.39e-05 | 199 | 136 | 6 | fa698f00d2dad74d28b4696c8c23dce70f123e52 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 3.39e-05 | 199 | 136 | 6 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | TCGA-Stomach-Primary_Tumor|TCGA-Stomach / Sample_Type by Project: Shred V9 | 3.39e-05 | 199 | 136 | 6 | 38f1f612b29feb868322999ceeda78e52447ec4f | |
| Drug | 0175029-0000 [211245-78-2]; Down 200; 10uM; PC3; HT_HG-U133A | 1.83e-06 | 186 | 136 | 9 | 6875_DN | |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 1.02e-05 | 174 | 136 | 8 | 7530_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A | 1.30e-05 | 180 | 136 | 8 | 4541_DN | |
| Drug | GW8510; Down 200; 10uM; MCF7; HT_HG-U133A | 1.47e-05 | 183 | 136 | 8 | 7062_DN | |
| Drug | daunorubicin HCl; Down 200; 1uM; MCF7; HT_HG-U133A | 2.00e-05 | 191 | 136 | 8 | 7507_DN | |
| Drug | Lysergol [602-85-7]; Up 200; 15.8uM; HL60; HT_HG-U133A | 2.68e-05 | 199 | 136 | 8 | 1325_UP | |
| Drug | haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A | 2.68e-05 | 199 | 136 | 8 | 6963_DN | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 1.78e-05 | 2 | 125 | 2 | 180849 | |
| Disease | Rubinstein-Taybi syndrome due to CREBBP mutations | 1.78e-05 | 2 | 125 | 2 | cv:C4551859 | |
| Disease | Menke-Hennekam syndrome | 1.78e-05 | 2 | 125 | 2 | cv:C5681632 | |
| Disease | Rubinstein-Taybi syndrome (implicated_via_orthology) | 1.78e-05 | 2 | 125 | 2 | DOID:1933 (implicated_via_orthology) | |
| Disease | Rubinstein-Taybi syndrome | 1.78e-05 | 2 | 125 | 2 | cv:C0035934 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 1.78e-05 | 2 | 125 | 2 | C4551859 | |
| Disease | Rubinstein-Taybi syndrome (is_implicated_in) | 1.78e-05 | 2 | 125 | 2 | DOID:1933 (is_implicated_in) | |
| Disease | Rubinstein-Taybi Syndrome | 1.78e-05 | 2 | 125 | 2 | C0035934 | |
| Disease | Paget's disease of bone (implicated_via_orthology) | 5.33e-05 | 3 | 125 | 2 | DOID:5408 (implicated_via_orthology) | |
| Disease | Adenocarcinoma of large intestine | 5.65e-05 | 96 | 125 | 5 | C1319315 | |
| Disease | Malignant neoplasm of endometrium | 5.78e-05 | 18 | 125 | 3 | C0007103 | |
| Disease | Carcinoma in situ of endometrium | 5.78e-05 | 18 | 125 | 3 | C0346191 | |
| Disease | Endometrial Carcinoma | 2.53e-04 | 72 | 125 | 4 | C0476089 | |
| Disease | Global developmental delay | 2.62e-04 | 133 | 125 | 5 | C0557874 | |
| Disease | Flaccid Muscle Tone | 2.64e-04 | 6 | 125 | 2 | C0026825 | |
| Disease | 4p partial monosomy syndrome | 2.64e-04 | 6 | 125 | 2 | cv:C1956097 | |
| Disease | Neonatal Hypotonia | 2.64e-04 | 6 | 125 | 2 | C2267233 | |
| Disease | WOLF-HIRSCHHORN SYNDROME | 2.64e-04 | 6 | 125 | 2 | 194190 | |
| Disease | Muscle Tone Atonic | 2.64e-04 | 6 | 125 | 2 | C0427202 | |
| Disease | Floppy Muscles | 2.64e-04 | 6 | 125 | 2 | C0427201 | |
| Disease | Unilateral Hypotonia | 2.64e-04 | 6 | 125 | 2 | C0751330 | |
| Disease | energy intake | 2.72e-04 | 134 | 125 | 5 | EFO_0003939 | |
| Disease | Prostatic Neoplasms | 3.02e-04 | 616 | 125 | 10 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 3.02e-04 | 616 | 125 | 10 | C0376358 | |
| Disease | urate measurement, bone density | FNBP1 HMGXB4 CCDC92 PPL DNAH1 DDX10 RABGAP1L PRKDC CPSF2 LRRFIP2 | 3.14e-04 | 619 | 125 | 10 | EFO_0003923, EFO_0004531 |
| Disease | Bladder Neoplasm | 3.33e-04 | 140 | 125 | 5 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 3.44e-04 | 141 | 125 | 5 | C0005684 | |
| Disease | Nemaline Myopathy, Childhood Onset | 3.69e-04 | 7 | 125 | 2 | C0546125 | |
| Disease | Primary ciliary dyskinesia | 4.78e-04 | 36 | 125 | 3 | cv:C0008780 | |
| Disease | Myopathies, Nemaline | 4.90e-04 | 8 | 125 | 2 | C0206157 | |
| Disease | Nemaline myopathy | 4.90e-04 | 8 | 125 | 2 | cv:C0206157 | |
| Disease | Pitt-Rogers-Danks Syndrome | 4.90e-04 | 8 | 125 | 2 | C0796117 | |
| Disease | Developmental delay (disorder) | 5.19e-04 | 37 | 125 | 3 | C0424605 | |
| Disease | Wolf-Hirschhorn Syndrome | 6.29e-04 | 9 | 125 | 2 | C1956097 | |
| Disease | subcutaneous adipose tissue measurement | 6.70e-04 | 93 | 125 | 4 | EFO_0004766 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 7.03e-04 | 41 | 125 | 3 | C0496956 | |
| Disease | Breast adenocarcinoma | 7.03e-04 | 41 | 125 | 3 | C0858252 | |
| Disease | Epilepsy, Myoclonic, Infantile | 7.84e-04 | 10 | 125 | 2 | C0917800 | |
| Disease | heparin-binding egf-like growth factor measurement | 7.84e-04 | 10 | 125 | 2 | EFO_0020438 | |
| Disease | alcohol use disorder measurement, alcohol consumption measurement | 7.85e-04 | 97 | 125 | 4 | EFO_0007878, EFO_0009458 | |
| Disease | systemic lupus erythematosus (implicated_via_orthology) | 8.09e-04 | 43 | 125 | 3 | DOID:9074 (implicated_via_orthology) | |
| Disease | mean corpuscular hemoglobin concentration | GIPC2 ATR POTEF ITSN1 MYO1B URB2 LBR NEB BAZ1A UBTF KIAA1217 PRKDC GOLGB1 | 8.44e-04 | 1105 | 125 | 13 | EFO_0004528 |
| Disease | Adenoid Cystic Carcinoma | 8.79e-04 | 100 | 125 | 4 | C0010606 | |
| Disease | immature platelet count | 1.09e-03 | 106 | 125 | 4 | EFO_0803544 | |
| Disease | Congenital myopathy (disorder) | 1.14e-03 | 12 | 125 | 2 | C0270960 | |
| Disease | immature platelet fraction | 1.43e-03 | 114 | 125 | 4 | EFO_0009187 | |
| Disease | C-X-C motif chemokine 11 measurement | 1.57e-03 | 14 | 125 | 2 | EFO_0008057 | |
| Disease | Small cell carcinoma of lung | 1.57e-03 | 54 | 125 | 3 | C0149925 | |
| Disease | myelodysplastic syndrome (implicated_via_orthology) | 1.80e-03 | 15 | 125 | 2 | DOID:0050908 (implicated_via_orthology) | |
| Disease | Adenocarcinoma of lung (disorder) | 1.88e-03 | 206 | 125 | 5 | C0152013 | |
| Disease | Squamous cell carcinoma | 1.95e-03 | 124 | 125 | 4 | C0007137 | |
| Disease | fourth ventricle volume measurement | 2.05e-03 | 16 | 125 | 2 | EFO_0010303 | |
| Disease | succinylcarnitine measurement | 2.05e-03 | 16 | 125 | 2 | EFO_0020020 | |
| Disease | Malignant neoplasm of breast | CENPF KIF16B ARHGEF38 THOC5 INPP4B BAP1 DDX10 MRPS7 EIF5 EP300 CUX1 GOLGB1 | 2.06e-03 | 1074 | 125 | 12 | C0006142 |
| Disease | docosahexaenoic acid measurement | 2.12e-03 | 127 | 125 | 4 | EFO_0007761 | |
| Disease | Muscle hypotonia | 2.32e-03 | 17 | 125 | 2 | C0026827 | |
| Disease | Chronic myeloproliferative disorder | 2.90e-03 | 19 | 125 | 2 | C1292778 | |
| Disease | Pancreatic carcinoma | 2.90e-03 | 19 | 125 | 2 | C0235974 | |
| Disease | Seckel syndrome | 3.89e-03 | 22 | 125 | 2 | C0265202 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 4.05e-03 | 152 | 125 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | melanoma | 4.17e-03 | 248 | 125 | 5 | C0025202 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YKKKLELKEDIVERL | 56 | Q14146 | |
| EELERKEKQYKKEVE | 461 | Q5TYW2 | |
| KIYKIQKELEEKRRT | 636 | Q09472 | |
| VVKLEEELKKKQVYV | 586 | Q4VCS5 | |
| EERKQFKDYEKKVKE | 1156 | Q8NDM7 | |
| KKVKELNEERDKYRK | 1166 | Q8NDM7 | |
| KRKKYTEDLDIKITD | 581 | Q9HCK8 | |
| ESRRKKKEYVECLEK | 306 | Q96BA8 | |
| VEELIEDKYKIILEK | 361 | Q8TC20 | |
| KEKKYIQEIKSITEI | 351 | Q8IVF6 | |
| EELERKEKQYKKEVE | 461 | Q5CZ79 | |
| EKEKAEREVSIKKYK | 1366 | Q9BXX2 | |
| ELEKQIVYLKEKVEK | 71 | A6NNP5 | |
| ELEEYLEKEKLKKEA | 391 | Q9P2I0 | |
| EKKLEKVKAYREKIE | 76 | Q04917 | |
| KVKAYREKIEKELET | 81 | Q04917 | |
| EVTIKALKEKIREYE | 136 | P39880 | |
| EQALRKKKYKVETEI | 316 | Q96DY2 | |
| EELERKEKQYKKEVE | 461 | Q4UJ75 | |
| EKIIKELIQTEKDYL | 96 | Q9NXL2 | |
| KRYTEEKERLEKKKE | 666 | Q8N4X5 | |
| DSLRKEKKYIQEIKS | 356 | A2A2Z9 | |
| EKIYKIQKELEEKRR | 656 | Q92793 | |
| YEACLKEEVEKRKKF | 646 | Q92560 | |
| YDVAKKLKELKKEEL | 176 | Q8TF65 | |
| DKLKSVLKKYAEVIE | 276 | Q9P1Z9 | |
| KYKETRLKEKEDALT | 251 | Q96KC8 | |
| KEREKLREEKRKYVE | 376 | Q9NRL2 | |
| EKDEQYAKLELEKKR | 736 | Q96L93 | |
| EKKYDLILKEEVKVT | 826 | Q09MP3 | |
| DKLKEYVKSLETKIA | 201 | Q9ULJ1 | |
| TEKEIDEIHSKYRKK | 331 | Q9NS91 | |
| KLKEIDSKEEKYVAK | 176 | Q14739 | |
| EKYHKKKAIVKEVID | 296 | O60870 | |
| EELERKEKQYKKEVE | 461 | Q5SQ80 | |
| LREKKYLEDIESVKK | 671 | A5A3E0 | |
| RRKYTLKIVEEETKK | 236 | P55081 | |
| KEKYEKRIIIKGVDA | 106 | Q8WZ60 | |
| EVEIRKKVLKIYNKR | 71 | P51948 | |
| CQKEREELKLKEKTY | 441 | Q9Y217 | |
| ILKKEYDQEREEKIK | 1966 | Q13439 | |
| KLEEQLKETVEKYKR | 66 | Q9HAV7 | |
| KTKKIKEKYTDREEL | 241 | Q58FF6 | |
| IQDIKTKYEKKLRDE | 871 | Q96MR6 | |
| EETKIKLTVYDVKDK | 106 | O15327 | |
| KIIVDKYVKDDKVNR | 1601 | Q15652 | |
| RHYEKDIKKVKEEKA | 221 | P83111 | |
| EEVEDLIVKYRKKKK | 271 | P80404 | |
| IKKELSKTGEEKYVE | 586 | O95202 | |
| KALKEKIREYEQTLK | 151 | Q13948 | |
| KIVIKKLDARKYEEN | 1041 | Q5H9U9 | |
| IRDKYGIKKKEEREA | 66 | O14810 | |
| DKRTLEKYEREAKEK | 231 | Q8IYD1 | |
| KKHEDVKQYKRTVIE | 361 | Q9BZD4 | |
| VEVKEVTKEVIKYKT | 1226 | O60437 | |
| KKEKLTLEFKIREEV | 591 | Q96Q89 | |
| KARKLKKIVEEKYEE | 356 | Q8NG66 | |
| RDFYNEKLEEIKEKK | 611 | Q8IUZ0 | |
| TQKKKADRYIEELTK | 186 | Q8N7Z2 | |
| KKKADRYIEELTKER | 176 | A8MZA4 | |
| KEVLKKYLESKEDVA | 456 | P32456 | |
| DKVRKYKKIVLDLLV | 81 | Q9BYG7 | |
| RYEKKLEELKAKEQS | 346 | Q9Y2C4 | |
| ELVIDDSYREIKKKK | 306 | Q9UGU5 | |
| IVKLLKKEYKEDLEK | 131 | Q9Y5B6 | |
| KEKVYEATIEEKTKE | 551 | P42694 | |
| KELKESLSEVEEKYK | 366 | Q9Y608 | |
| SKKVVEDIEYLKFDK | 266 | O95299 | |
| RKQLEKAEYEIKKTT | 91 | B7ZAP0 | |
| EDLKARYHDEKKIIK | 666 | O75400 | |
| RYHDEKKIIKDILKD | 671 | O75400 | |
| LREKKYLEDIESVKK | 671 | Q6S8J3 | |
| QKERYEKEKTFKRKE | 376 | Q9BZI7 | |
| DEEKKLYLVHKTDEK | 311 | Q9P2D7 | |
| EELERKEKQYKKEVE | 461 | Q5VUR7 | |
| LKKIKAVLQEYRKET | 1261 | Q13535 | |
| KYVSKELAKEIRVKA | 361 | P55010 | |
| KDVVRAYKSLLKEKE | 36 | Q96CN9 | |
| EKSIEERKKVFKDVL | 276 | Q9BX69 | |
| ELKELKKKVTAKIDY | 141 | Q14185 | |
| SESEYIEEVRAKKKK | 196 | Q5BKY9 | |
| DLKEKYNKEVEERKR | 166 | P49454 | |
| ALELKKKEYEELKEE | 601 | P49454 | |
| KKEYEELKEEKTLFS | 606 | P49454 | |
| EKYIKFVKERTEIEL | 26 | Q96RU3 | |
| KKVKAEVEDLKYLLD | 1681 | O15078 | |
| YKEEVKKNILLEEKV | 2431 | O15078 | |
| NTIKEREKKYLEELK | 121 | Q53HC0 | |
| EDEAVYKAKIEKKAI | 61 | P0C843 | |
| IKAASELYIETEKKK | 1566 | Q15811 | |
| RRLQAKVEKYEEKEK | 136 | Q9NQY0 | |
| IKDVKYLKEEDANRK | 166 | Q8N3J6 | |
| KDYETKFTKIEKEKR | 171 | Q9ULH1 | |
| YRAKDKKTDEIVALK | 441 | Q9UQ88 | |
| VKKADVLKILKDYDR | 61 | O15182 | |
| ADKESEKVSYVIKKL | 686 | Q6ZN28 | |
| DKEEYRKKIKAKHRE | 736 | Q13206 | |
| QLVRRYKKLKVEKEE | 326 | O95718 | |
| TKEEYKEIVRKAVDK | 1401 | Q99590 | |
| EKLKYEEKATKDLER | 616 | P54277 | |
| YKKEKARVITEEEKN | 161 | P26373 | |
| VVKKLDREKEDKYLF | 556 | Q9BZA8 | |
| KVYIGEEEKKIFLEK | 251 | Q8TBX8 | |
| RKYVKAKKSIDKDEE | 161 | Q9Y2M0 | |
| TKEIEEYKKSVVSLK | 286 | P82673 | |
| KLYEKRKVAALEIEK | 21 | Q08AM6 | |
| EEKYVRELKKTQLIK | 61 | Q9Y2R9 | |
| AKRIKNDKTEKEIYT | 296 | Q9NUP7 | |
| IAEKIIAKYKAKEEE | 351 | Q6DKJ4 | |
| YKKVEIKELGELRKE | 306 | P09758 | |
| EKVKYLQKAKTREEI | 106 | Q6PI97 | |
| FEDIYIERKKTIKII | 1211 | Q15858 | |
| IERKKTIKIILEYAD | 1216 | Q15858 | |
| VETEKEKILRKEYVF | 361 | Q92835 | |
| RQKYLHEEEKIVKKL | 711 | Q5T5P2 | |
| VKEKKEAITYREVLE | 16 | O60902 | |
| KREYKLRKEQLKEEL | 556 | Q7L7X3 | |
| KLAESVEKAIEEKKY | 216 | Q9Y5B9 | |
| KEVQKRYKTREAEEK | 626 | Q9Y5B9 | |
| KDDIFRIYIKEKKEC | 91 | Q13501 | |
| DYIIKEKTVLLQKKD | 656 | Q9Y566 | |
| RYLVEKEKLEKEKET | 621 | Q8TED9 | |
| EEYKKEVERKKLELD | 566 | P35612 | |
| KDKKEYTRTVKLEEV | 751 | A4UGR9 | |
| EEKAKKVRSEYEKKL | 711 | Q7Z4S6 | |
| KKDITKEEYKDILRK | 1231 | Q9H7N4 | |
| KEEYKDILRKAVHKI | 1236 | Q9H7N4 | |
| LKIDEDYKEKTVIDK | 171 | Q07617 | |
| VDVEKYAKVEKSIKS | 306 | Q8NEM7 | |
| EVYELKKKVIERLED | 206 | A6NFE2 | |
| YRKLQDIKEKETDKI | 96 | A2RU48 | |
| ELKKKVEYKREEINS | 171 | Q495X7 | |
| DEVRRKKAVYKKAEL | 1456 | P11137 | |
| KKKYIEIRKEAREAA | 2001 | P78527 | |
| KKLETREVVDLSKYK | 1216 | Q9BZF9 | |
| EIIDEDKKKSTKDRY | 116 | Q6ZMS4 | |
| KKLFLKKEIYEIEST | 86 | Q969W8 | |
| NKEKILKEIEVKKEY | 211 | Q13769 | |
| KCDQKKKDYEVELLR | 346 | P17480 | |
| EKTVRDKEYKALQIK | 416 | Q9NUQ3 | |
| KYEEEIKILTDKLKE | 221 | P06753 | |
| KEKYKVKDRIEEKTR | 281 | Q5T200 | |
| VKEKTKVESEIRKEY | 1976 | Q14789 | |
| RKKILEEVMEKETYK | 116 | Q9C0E8 | |
| YKKLKDAIEEKIIIA | 976 | O43795 | |
| ENIKEIRDKYEKKAT | 621 | O14777 | |
| RKVKDEVSDLKYKEV | 5501 | P20929 | |
| IESDLKYKEKHVKER | 5611 | P20929 |